HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"recordsFiltered": 47671,
"recordsTotal": 47671,
"next": "http://fdaaa.trialstracker.net/api/trials/?format=api&length=300&ordering=-title&start=46800",
"previous": "http://fdaaa.trialstracker.net/api/trials/?format=api&length=300&ordering=-title&start=46200",
"results": [
{
"registry_id": "NCT07284290",
"publication_url": "https://clinicaltrials.gov/study/NCT07284290",
"title": "Elucidating the Role of Cholinergic Degeneration in Cognitive Fluctuations in Lewy Body Dementia",
"has_exemption": false,
"start_date": "2026-01-25",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Virginia Commonwealth University",
"sponsor_slug": "virginia-commonwealth-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07188896",
"publication_url": "https://clinicaltrials.gov/study/NCT07188896",
"title": "A Randomized Phase 2 Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC)",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Brian Rini",
"sponsor_slug": "brian-rini",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07094542",
"publication_url": "https://clinicaltrials.gov/study/NCT07094542",
"title": "Temporo-masseteric Nerve Block in Post-wisdom Tooth Extraction Pain- a Randomized Study",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Rutgers, The State University of New Jersey",
"sponsor_slug": "rutgers-the-state-university-of-new-jersey",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07342439",
"publication_url": "https://clinicaltrials.gov/study/NCT07342439",
"title": "Phase 3 Study of Serine Supplementation to Protect Vision in MacTel",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "The Lowy Medical Research Institute Limited",
"sponsor_slug": "the-lowy-medical-research-institute-limited",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT00610051",
"publication_url": "https://clinicaltrials.gov/study/NCT00610051",
"title": "Phase 3 Study of Alprostadil Continuous Intravenous Infusion to Maintain Clinical Stability in Severe Heart Failure Patients",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Biopeutics Co., Ltd",
"sponsor_slug": "biopeutics-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06660862",
"publication_url": "https://clinicaltrials.gov/study/NCT06660862",
"title": "DAROSTEP: Evaluating Step Counts as a Biomarker and Its Relationship on Treatment Outcomes in Vulnerable Patients With Metastatic Hormone-Sensitive Prostate Cancer on Darolutamide and Androgen Deprivation Therapy",
"has_exemption": false,
"start_date": "2026-11-30",
"completion_date": "2029-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01581580",
"publication_url": "https://clinicaltrials.gov/study/NCT01581580",
"title": "Deep Brain Stimulation Surgery for Movement Disorders",
"has_exemption": false,
"start_date": "2011-08-17",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Neurological Disorders and Stroke (NINDS)",
"sponsor_slug": "national-institute-of-neurological-disorders-and-stroke-ninds",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT04374305",
"publication_url": "https://clinicaltrials.gov/study/NCT04374305",
"title": "Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)",
"has_exemption": false,
"start_date": "2020-06-20",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Scott R. Plotkin, MD, PhD",
"sponsor_slug": "scott-r-plotkin-md-phd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04532424",
"publication_url": "https://clinicaltrials.gov/study/NCT04532424",
"title": "Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD",
"has_exemption": false,
"start_date": "2021-01-04",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04240054",
"publication_url": "https://clinicaltrials.gov/study/NCT04240054",
"title": "A Multisite, Phase II Study of Bortezomib, Isatuximab, Cyclophosphamide and Dexamethasone (VICD) Induction in Transplant-Eligible Multiple Myeloma Patients With Renal Insufficiency",
"has_exemption": false,
"start_date": "2021-11-02",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06043817",
"publication_url": "https://clinicaltrials.gov/study/NCT06043817",
"title": "First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations",
"has_exemption": false,
"start_date": "2023-09-26",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Pierre Fabre Medicament",
"sponsor_slug": "pierre-fabre-medicament",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06447103",
"publication_url": "https://clinicaltrials.gov/study/NCT06447103",
"title": "89Zr-DFO-GmAb PET/CT vs Contrast-Enhanced CT for Detection of Recurrent Clear Cell Renal Cell Carcinoma After Surgery",
"has_exemption": false,
"start_date": "2024-08-06",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06739356",
"publication_url": "https://clinicaltrials.gov/study/NCT06739356",
"title": "North American Fetal Therapy Network Prospective Registry for Long-term Outcome Following Fetoscopic Endoluminal Tracheal Occlusion in Severe Left and Right Congenital Diaphragmatic Hernia",
"has_exemption": false,
"start_date": "2025-03-04",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center, Houston",
"sponsor_slug": "the-university-of-texas-health-science-center-houston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07166172",
"publication_url": "https://clinicaltrials.gov/study/NCT07166172",
"title": "North American Fetal Therapy Network Prospective Registry for Long-term Outcome Following Fetoscopic Endoluminal Tracheal Occlusion in Severe Left and Right Congenital Diaphragmatic Hernia",
"has_exemption": false,
"start_date": "2025-06-23",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06077071",
"publication_url": "https://clinicaltrials.gov/study/NCT06077071",
"title": "MRIdian \"RADAR\" Trial - Radiosurgical Debulking of Asymptomatic/Radiographic Spinal Cord Compression Using Stereotactic MRI-guided Adaptive Radiotherapy",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07096778",
"publication_url": "https://clinicaltrials.gov/study/NCT07096778",
"title": "A Phase II, Open-Label, Multicenter Study of Inobrodib in Combination With Pomalidomide and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "CellCentric Ltd.",
"sponsor_slug": "cellcentric-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07222215",
"publication_url": "https://clinicaltrials.gov/study/NCT07222215",
"title": "A Phase II Multi-Center Open-label Randomized Study of CAPecitabine in Combination With ELAcestrant Versus Capecitabine Alone in Advanced Estrogen Receptor-Positive Breast Cancer (CAPELA)",
"has_exemption": false,
"start_date": "2026-01-16",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Kristina A. Fanucci",
"sponsor_slug": "kristina-a-fanucci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07328490",
"publication_url": "https://clinicaltrials.gov/study/NCT07328490",
"title": "A Phase I/II Study to Assess the Safety and Antitumor Activity of Bispecific T-cell Engager Tarlatamab and TROP2 Targeted Antibody Drug Conjugate Sacituzumab Govitecan in Previously Treated Extensive-Stage Small Cell Lung Cancer and Extrapulmonary Neuroendocrine Cancer",
"has_exemption": false,
"start_date": "2026-02-01",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07296094",
"publication_url": "https://clinicaltrials.gov/study/NCT07296094",
"title": "Psilocybin-Assisted Psychotherapy for the Treatment of Severe Alcohol Use Disorder: A Double-Blind, Dose-Comparison Concurrent Control Randomized Trial",
"has_exemption": false,
"start_date": "2026-05-01",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05479643",
"publication_url": "https://clinicaltrials.gov/study/NCT05479643",
"title": "A Pilot Study for a Novel and Personalized Voice Restoration Device for Patients With Laryngectomy",
"has_exemption": false,
"start_date": "2027-12-01",
"completion_date": "2029-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Weill Medical College of Cornell University",
"sponsor_slug": "weill-medical-college-of-cornell-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05714839",
"publication_url": "https://clinicaltrials.gov/study/NCT05714839",
"title": "A Phase 1/2 Open-label, Multicentre, Dose Escalation and Expansion Study to Investigate the Safety, Tolerability, and Clinical Activity of Belantamab as Monotherapy and in Combination With Other Treatments in Participants With Multiple Myeloma",
"has_exemption": false,
"start_date": "2023-06-14",
"completion_date": "2029-12-03",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05130437",
"publication_url": "https://clinicaltrials.gov/study/NCT05130437",
"title": "A Phase 1/2, Global, Open-Label, Extension Study to Evaluate the Long-Term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled in the mRNA-3927-P101 Study",
"has_exemption": false,
"start_date": "2021-11-09",
"completion_date": "2029-12-04",
"has_results": false,
"results_due": false,
"sponsor_name": "ModernaTX, Inc.",
"sponsor_slug": "modernatx-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06449651",
"publication_url": "https://clinicaltrials.gov/study/NCT06449651",
"title": "Double-blind, Randomized, Placebo-controlled Study Evaluating the Safety and Efficacy of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) in At-risk Pregnancies",
"has_exemption": false,
"start_date": "2024-11-11",
"completion_date": "2029-12-05",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06381154",
"publication_url": "https://clinicaltrials.gov/study/NCT06381154",
"title": "Photodynamic Priming to Facilitate Immunologic Activity of Anti-PD1 in Patients With Pancreatic Cancer",
"has_exemption": false,
"start_date": "2024-12-06",
"completion_date": "2029-12-06",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07190248",
"publication_url": "https://clinicaltrials.gov/study/NCT07190248",
"title": "A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy of MK-1084 in Combination With Subcutaneous Pembrolizumab and Berahyaluronidase Alfa (MK-3475A) Versus MK-3475A in Combination With Pemetrexed/Platinum (Carboplatin or Cisplatin) Chemotherapy as First-line Treatment of Participants With KRAS G12C-Mutant, Advanced or Metastatic Nonsquamous NSCLC (KANDLELIT-007)",
"has_exemption": false,
"start_date": "2025-10-08",
"completion_date": "2029-12-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06804642",
"publication_url": "https://clinicaltrials.gov/study/NCT06804642",
"title": "Rehabilitation of Locomotor Function in Parkinson's Disease by Non-invasive Spinal Cord Stimulation",
"has_exemption": false,
"start_date": "2024-12-12",
"completion_date": "2029-12-11",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Louisville",
"sponsor_slug": "university-of-louisville",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06747949",
"publication_url": "https://clinicaltrials.gov/study/NCT06747949",
"title": "A Multicenter, Open-Label, Long-term, Extension Study to Evaluate the Safety and Tolerability of Dazodalibep in Participants With Sjögren's Syndrome (SS)",
"has_exemption": false,
"start_date": "2025-02-25",
"completion_date": "2029-12-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07064473",
"publication_url": "https://clinicaltrials.gov/study/NCT07064473",
"title": "A Phase III Double-blind, Randomised, Parallel-group Superiority Trial to Evaluate Efficacy and Safety of the Combined Use of Oral Vicadrostat (BI 690517) and Empagliflozin Compared With Placebo and Empagliflozin in Participants With Type 2 Diabetes, Hypertension and Established Cardiovascular Disease",
"has_exemption": false,
"start_date": "2025-07-22",
"completion_date": "2029-12-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Boehringer Ingelheim",
"sponsor_slug": "boehringer-ingelheim",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04482933",
"publication_url": "https://clinicaltrials.gov/study/NCT04482933",
"title": "Phase II Clinical Trial of HSV G207 With a Single 5 Gy Radiation Dose in Children With Recurrent High-Grade Glioma",
"has_exemption": false,
"start_date": "2025-09-01",
"completion_date": "2029-12-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Pediatric Brain Tumor Consortium",
"sponsor_slug": "pediatric-brain-tumor-consortium",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06677060",
"publication_url": "https://clinicaltrials.gov/study/NCT06677060",
"title": "A Phase III, Randomised, Placebo-controlled, Event-driven Study to Evaluate the Effect of Baxdrostat in Combination With Dapagliflozin Compared With Dapagliflozin Alone on the Risk of Incident Heart Failure and Cardiovascular Death",
"has_exemption": false,
"start_date": "2025-03-14",
"completion_date": "2029-12-17",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03340506",
"publication_url": "https://clinicaltrials.gov/study/NCT03340506",
"title": "Open Label, Multi-center Roll-over Study to Assess Long Term Safety in Patients Who Have Completed a Global Novartis or GSK Sponsored Dabrafenib and/or Trametinib Study",
"has_exemption": false,
"start_date": "2017-12-28",
"completion_date": "2029-12-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06742723",
"publication_url": "https://clinicaltrials.gov/study/NCT06742723",
"title": "A Phase III, Randomised, Double-blind, Placebo-controlled, Event-driven Study to Assess the Efficacy, Safety and Tolerability of Baxdrostat in Combination With Dapagliflozin Compared With Dapagliflozin Alone on Renal Outcomes and Cardiovascular Mortality in Participants With Chronic Kidney Disease and High Blood Pressure",
"has_exemption": false,
"start_date": "2025-03-03",
"completion_date": "2029-12-18",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07288567",
"publication_url": "https://clinicaltrials.gov/study/NCT07288567",
"title": "A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (13 to 17 Years of Age)",
"has_exemption": false,
"start_date": "2026-01-27",
"completion_date": "2029-12-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07286058",
"publication_url": "https://clinicaltrials.gov/study/NCT07286058",
"title": "A Phase 3, Multicenter, Long-Term Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of Zasocitinib (TAK-279) in Subjects With Active Psoriatic Arthritis Who Are Either Biologic DMARD-Naïve or Biologic DMARD-Experienced, Including Those With Inadequate Response to Biologic DMARDs",
"has_exemption": false,
"start_date": "2026-02-27",
"completion_date": "2029-12-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03684018",
"publication_url": "https://clinicaltrials.gov/study/NCT03684018",
"title": "Randomized Study of Two Dose Levels of Privigen in Pediatric CIDP",
"has_exemption": false,
"start_date": "2019-02-28",
"completion_date": "2029-12-20",
"has_results": false,
"results_due": false,
"sponsor_name": "CSL Behring",
"sponsor_slug": "csl-behring",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04684368",
"publication_url": "https://clinicaltrials.gov/study/NCT04684368",
"title": "A Phase 2 Trial of Chemotherapy Followed by Response-Based Whole Ventricular &Amp; Spinal Canal Irradiation (WVSCI) for Patients With Localized Non-Germinomatous Central Nervous System Germ Cell Tumor",
"has_exemption": false,
"start_date": "2021-07-13",
"completion_date": "2029-12-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Oncology Group",
"sponsor_slug": "childrens-oncology-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06907147",
"publication_url": "https://clinicaltrials.gov/study/NCT06907147",
"title": "Global Pilot Study of rEnal and Hepatic coMbINed denervatIon in Subjects With Uncontrolled Hypertension With and Without High Cardiovascular Risk",
"has_exemption": false,
"start_date": "2025-05-01",
"completion_date": "2029-12-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Medtronic Vascular",
"sponsor_slug": "medtronic-vascular",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05844982",
"publication_url": "https://clinicaltrials.gov/study/NCT05844982",
"title": "A Trial Evaluating Intravitreal Faricimab (6.0 mg) Injections or Fluocinolone Acetonide (0.19 mg Intravitreal Implants vs Observation for Prevention of Visual Acuity Loss Due to Radiation Retinopathy",
"has_exemption": false,
"start_date": "2023-11-21",
"completion_date": "2029-12-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Jaeb Center for Health Research",
"sponsor_slug": "jaeb-center-for-health-research",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06716606",
"publication_url": "https://clinicaltrials.gov/study/NCT06716606",
"title": "An Open Label Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD)",
"has_exemption": false,
"start_date": "2024-12-12",
"completion_date": "2029-12-27",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05910801",
"publication_url": "https://clinicaltrials.gov/study/NCT05910801",
"title": "Tafasitamab, Lenalidomide and Venetoclax Combination Therapy for Relapsed or Refractory Mantle Cell Lymphoma (V-MIND): a Phase II Study with Safety Lead-In",
"has_exemption": false,
"start_date": "2024-01-04",
"completion_date": "2029-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Academic and Community Cancer Research United",
"sponsor_slug": "academic-and-community-cancer-research-united",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06764615",
"publication_url": "https://clinicaltrials.gov/study/NCT06764615",
"title": "A Phase 2, Open-Label Extension Trial to Evaluate the Long-term Safety and Tolerability of Oral Zasocitinib (TAK-279) in Participants With Moderately to Severely Active Ulcerative Colitis and Moderately to Severely Active Crohn's Disease",
"has_exemption": false,
"start_date": "2025-05-28",
"completion_date": "2029-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05569486",
"publication_url": "https://clinicaltrials.gov/study/NCT05569486",
"title": "Elucidating the Central Mechanism(s) of Action for Green Light Therapy in Managing Chronic Pain",
"has_exemption": false,
"start_date": "2026-01-01",
"completion_date": "2029-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Arizona",
"sponsor_slug": "university-of-arizona",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT00262470",
"publication_url": "https://clinicaltrials.gov/study/NCT00262470",
"title": "Treatment of Orthostatic Intolerance",
"has_exemption": false,
"start_date": "1997-04-30",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Satish R. Raj",
"sponsor_slug": "satish-r-raj",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT01841723",
"publication_url": "https://clinicaltrials.gov/study/NCT01841723",
"title": "A Multicenter Phase 2 Study of the Bruton's Tyrosine Kinase Inhibitor PCI-32765 (Ibrutinib) for Treatment of Relapsed Hairy Cell Leukemia",
"has_exemption": false,
"start_date": "2013-04-30",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02582697",
"publication_url": "https://clinicaltrials.gov/study/NCT02582697",
"title": "Phase 3 Accelerated BEP: A Randomised Phase 3 Trial of Accelerated Versus Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours",
"has_exemption": false,
"start_date": "2014-02-28",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Sydney",
"sponsor_slug": "university-of-sydney",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03075696",
"publication_url": "https://clinicaltrials.gov/study/NCT03075696",
"title": "A Multicenter, Open-label, Phase I/II Study to Evaluate the Safety, Efficacy, Tolerability and Pharmacokinetics of Escalating Doses of Glofitamab (RO7082859) as a Single Agent and in Combination With Obinutuzumab Administered After a Fixed, Single Dose Pre-treatment of Obinutuzumab (Gazyva®/Gazyvaro™) in Patients With Relapsed/Refractory B-cell Non-hodgkin's Lymphoma",
"has_exemption": false,
"start_date": "2017-02-21",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03181867",
"publication_url": "https://clinicaltrials.gov/study/NCT03181867",
"title": "18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer",
"has_exemption": false,
"start_date": "2017-08-03",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06984757",
"publication_url": "https://clinicaltrials.gov/study/NCT06984757",
"title": "Mid-frontal Delta/Theta and Cognitive Control",
"has_exemption": false,
"start_date": "2017-09-25",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Nandakumar Narayanan",
"sponsor_slug": "nandakumar-narayanan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03373968",
"publication_url": "https://clinicaltrials.gov/study/NCT03373968",
"title": "Open Label, Long-term Safety, Tolerability, and Efficacy Study of GIVINOSTAT in All DMD Patients Who Have Been Previously Treated in One of the GIVINOSTAT Studies",
"has_exemption": false,
"start_date": "2017-10-24",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Italfarmaco",
"sponsor_slug": "italfarmaco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03998527",
"publication_url": "https://clinicaltrials.gov/study/NCT03998527",
"title": "Non-Invasive Spinal Cord Stimulation and Respiratory Plasticity",
"has_exemption": false,
"start_date": "2018-05-17",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Louisville",
"sponsor_slug": "university-of-louisville",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03599765",
"publication_url": "https://clinicaltrials.gov/study/NCT03599765",
"title": "External Beam Radiation to Eliminate Nominal Metastatic Disease (EXTEND): A Randomized Phase II Basket Trial Assessing the Efficacy of Upfront Local Consolidative Therapy (LCT) for Oligometastatic Disease",
"has_exemption": false,
"start_date": "2018-07-31",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03913559",
"publication_url": "https://clinicaltrials.gov/study/NCT03913559",
"title": "Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia",
"has_exemption": false,
"start_date": "2019-05-14",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Jude Children's Research Hospital",
"sponsor_slug": "st-jude-childrens-research-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03474029",
"publication_url": "https://clinicaltrials.gov/study/NCT03474029",
"title": "Six Weeks of Daily Rifapentine vs. a Comparator Arm of 12-16 Week Rifamycin-based Treatment of Latent M. Tuberculosis Infection: Assessment of Safety, Tolerability and Effectiveness",
"has_exemption": false,
"start_date": "2019-08-01",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Centers for Disease Control and Prevention",
"sponsor_slug": "centers-for-disease-control-and-prevention",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03937635",
"publication_url": "https://clinicaltrials.gov/study/NCT03937635",
"title": "Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM)",
"has_exemption": false,
"start_date": "2019-09-16",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "ECOG-ACRIN Cancer Research Group",
"sponsor_slug": "ecog-acrin-cancer-research-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03911700",
"publication_url": "https://clinicaltrials.gov/study/NCT03911700",
"title": "Prospective, Multi-Center, Open-Label, Randomized, Controlled Trial of Phasix™ Mesh to Prevent Incisional Hernia Subsequent to Open Midline Laparotomy",
"has_exemption": false,
"start_date": "2019-12-12",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "C. R. Bard",
"sponsor_slug": "c-r-bard",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04166318",
"publication_url": "https://clinicaltrials.gov/study/NCT04166318",
"title": "A Randomized Phase II Study of De-Intensified ChemoRadiation for Early-Stage Anal Squamous Cell Carcinoma (DECREASE)",
"has_exemption": false,
"start_date": "2020-01-02",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "ECOG-ACRIN Cancer Research Group",
"sponsor_slug": "ecog-acrin-cancer-research-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03971799",
"publication_url": "https://clinicaltrials.gov/study/NCT03971799",
"title": "Phase 1/2 Study of Anti-CD33 Chimeric Antigen Receptor-Expressing T Cells (CD33CART) in Children and Young Adults With Relapsed/Refractory Acute Myeloid Leukemia",
"has_exemption": false,
"start_date": "2020-01-08",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Center for International Blood and Marrow Transplant Research",
"sponsor_slug": "center-for-international-blood-and-marrow-transplant-research",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04516135",
"publication_url": "https://clinicaltrials.gov/study/NCT04516135",
"title": "A Randomized Phase II Trial of Palliative Pelvic Radiation Therapy to Improve Health Related Quality of Life in Gynecologic Malignancies",
"has_exemption": false,
"start_date": "2021-01-11",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04661358",
"publication_url": "https://clinicaltrials.gov/study/NCT04661358",
"title": "A Randomized Clinical Trial Evaluating Fenofibrate for Prevention of Diabetic Retinopathy Worsening",
"has_exemption": false,
"start_date": "2021-03-05",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Jaeb Center for Health Research",
"sponsor_slug": "jaeb-center-for-health-research",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04746677",
"publication_url": "https://clinicaltrials.gov/study/NCT04746677",
"title": "Single-Center Investigational Device Exemption Trial: Safety and Efficacy of Endovascular Repair of Complex Aortic Pathology With Physician-modified Endovascular Grafts (PMEGs)",
"has_exemption": false,
"start_date": "2021-03-15",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Beth Israel Deaconess Medical Center",
"sponsor_slug": "beth-israel-deaconess-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04474847",
"publication_url": "https://clinicaltrials.gov/study/NCT04474847",
"title": "A Randomized Double-Blind, Placebo Controlled Trial of Abatacept (CTLA4-Ig) in Giant Cell Arteritis (ABAGART)",
"has_exemption": false,
"start_date": "2021-03-29",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Pennsylvania",
"sponsor_slug": "university-of-pennsylvania",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04774159",
"publication_url": "https://clinicaltrials.gov/study/NCT04774159",
"title": "Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk: A Randomized Trial",
"has_exemption": false,
"start_date": "2021-05-06",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Population Health Research Institute",
"sponsor_slug": "population-health-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05269004",
"publication_url": "https://clinicaltrials.gov/study/NCT05269004",
"title": "A Multicenter, Single-Arm, Open-Label, Extension, Rollover Study To Evaluate The Long-Term Safety And Efficacy Of Ocrelizumab In Patients With Multiple Sclerosis",
"has_exemption": false,
"start_date": "2022-05-03",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05183646",
"publication_url": "https://clinicaltrials.gov/study/NCT05183646",
"title": "A Pivotal Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of DMX-200 in Patients With Focal Segmental Glomerulosclerosis (FSGS) Who Are Receiving an Angiotensin II Receptor Blocker (ARB)",
"has_exemption": false,
"start_date": "2022-05-30",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Dimerix Bioscience Pty Ltd",
"sponsor_slug": "dimerix-bioscience-pty-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06946264",
"publication_url": "https://clinicaltrials.gov/study/NCT06946264",
"title": "Characterization of Bronchodilator Response in Children With Bronchiolitis Using Phenotypic and Genotypic Features",
"has_exemption": false,
"start_date": "2022-07-08",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Nemours Children's Clinic",
"sponsor_slug": "nemours-childrens-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05409066",
"publication_url": "https://clinicaltrials.gov/study/NCT05409066",
"title": "A Phase 3, Open-Label Study to Evaluate Safety and Efficacy of Epcoritamab in Combination With Rituximab and Lenalidomide (R2) Compared to R2 in Subjects With Relapsed or Refractory Follicular Lymphoma (EPCORE FL-1)",
"has_exemption": false,
"start_date": "2022-09-20",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Genmab",
"sponsor_slug": "genmab",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05527340",
"publication_url": "https://clinicaltrials.gov/study/NCT05527340",
"title": "Multicenter, Phase II, National and Open-label Study to Evaluate Iberdomide-dexamethasone Alone or in Combination With Standard MM Treatment Regimens in Transplant Ineligible Newly Diagnosed Patients.",
"has_exemption": false,
"start_date": "2022-09-30",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "PETHEMA Foundation",
"sponsor_slug": "pethema-foundation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05776069",
"publication_url": "https://clinicaltrials.gov/study/NCT05776069",
"title": "A Multi-Modular Trial to Evaluate VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease and Other Bleeding Disorders (VIVID)",
"has_exemption": false,
"start_date": "2023-03-16",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Vega Therapeutics, Inc",
"sponsor_slug": "vega-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05898620",
"publication_url": "https://clinicaltrials.gov/study/NCT05898620",
"title": "A Baseline-Controlled, Open-Label, Multicenter, Single-Arm, Pivotal Study to Evaluate the Efficacy, Safety, and Tolerability of NGN-401 in Subjects With Rett Syndrome (Embolden)",
"has_exemption": false,
"start_date": "2023-06-13",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Neurogene Inc.",
"sponsor_slug": "neurogene-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05616546",
"publication_url": "https://clinicaltrials.gov/study/NCT05616546",
"title": "Longitudinal Analysis of Bone Marrow and Peripheral Blood Immune Responses to Influenza Vaccination in a Healthy Adult Cohort",
"has_exemption": false,
"start_date": "2023-10-16",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06126380",
"publication_url": "https://clinicaltrials.gov/study/NCT06126380",
"title": "AT-1501-K209: BESTOW-EXTENSION: A Phase 2, Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant Recipients",
"has_exemption": false,
"start_date": "2023-10-25",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eledon Pharmaceuticals",
"sponsor_slug": "eledon-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05977751",
"publication_url": "https://clinicaltrials.gov/study/NCT05977751",
"title": "FINALE: Prospective Multi-Center Trial for FemBloc INtratubal Occlusion for TranscervicAL PErmanent Birth Control",
"has_exemption": false,
"start_date": "2023-10-31",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Femasys Inc.",
"sponsor_slug": "femasys-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06105749",
"publication_url": "https://clinicaltrials.gov/study/NCT06105749",
"title": "Outcome of Biennial Screening Contrast-Enhanced Mammography (CEM) in Women With a Personal History of Breast Cancer (PHBC)",
"has_exemption": false,
"start_date": "2023-11-08",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Wendie Berg",
"sponsor_slug": "wendie-berg",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06084234",
"publication_url": "https://clinicaltrials.gov/study/NCT06084234",
"title": "National Liver Cancer Screening Trial",
"has_exemption": false,
"start_date": "2023-12-26",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07325175",
"publication_url": "https://clinicaltrials.gov/study/NCT07325175",
"title": "Quantifying Motor Network Dynamics to Predict and Enhance Outcomes in Pediatric Dystonia",
"has_exemption": false,
"start_date": "2024-01-01",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital Medical Center, Cincinnati",
"sponsor_slug": "childrens-hospital-medical-center-cincinnati",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06238648",
"publication_url": "https://clinicaltrials.gov/study/NCT06238648",
"title": "Multicenter, Randomized Phase II Study of Epcoritamab for Patients With Aggressive B-Cell Lymphomas Achieving a Partial Response After CD19-Directed CAR-T Therapy",
"has_exemption": false,
"start_date": "2024-01-31",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Academic and Community Cancer Research United",
"sponsor_slug": "academic-and-community-cancer-research-united",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06264609",
"publication_url": "https://clinicaltrials.gov/study/NCT06264609",
"title": "Novel Precision Medicine Approach to Treatment of Osteoporosis Based on Bone Turnover - Follow Up Study",
"has_exemption": false,
"start_date": "2024-02-01",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Paul F Netzel",
"sponsor_slug": "paul-f-netzel",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06164275",
"publication_url": "https://clinicaltrials.gov/study/NCT06164275",
"title": "A Phase II Multi-Center Open-Label Trial of Six Doses of Pembrolizumab Monotherapy Prior to Limited Chemotherapy as Front-Line Therapy for Patients With Classical Hodgkin Lymphoma, Including Elderly Patients.",
"has_exemption": false,
"start_date": "2024-02-06",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwestern University",
"sponsor_slug": "northwestern-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06121297",
"publication_url": "https://clinicaltrials.gov/study/NCT06121297",
"title": "A Phase 1/2, Open-label Study to Evaluate the Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T Cells (CABA-201) in Subjects With Active Systemic Lupus Erythematosus",
"has_exemption": false,
"start_date": "2024-02-16",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Cabaletta Bio",
"sponsor_slug": "cabaletta-bio",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06227949",
"publication_url": "https://clinicaltrials.gov/study/NCT06227949",
"title": "FSH and LH Versus FSH Alone for Ovarian Stimulation in Non-hormone Sensitive Onco-fertility Patients: an Exploratory Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2024-02-29",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ellen Greenblatt",
"sponsor_slug": "ellen-greenblatt",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06292208",
"publication_url": "https://clinicaltrials.gov/study/NCT06292208",
"title": "Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetic (PK) and Preliminary Efficacy of IBD0333 in Patients With Locally Advanced/Metastatic Solid Tumor or Non-Hodgkin Lymphoma",
"has_exemption": false,
"start_date": "2024-03-09",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "SUNHO（China）BioPharmaceutical CO., Ltd.",
"sponsor_slug": "sunhochinabiopharmaceutical-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06216470",
"publication_url": "https://clinicaltrials.gov/study/NCT06216470",
"title": "Phase II Investigator-Initiated Study to Understand the Vaccinal Effect of HBsAg Monoclonal Ab VIR-3434 in Chronic Hepatitis B Infection",
"has_exemption": false,
"start_date": "2024-03-13",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University Health Network, Toronto",
"sponsor_slug": "university-health-network-toronto",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06172296",
"publication_url": "https://clinicaltrials.gov/study/NCT06172296",
"title": "A Phase 3 Study of Dinutuximab Added to Intensive Multimodal Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma",
"has_exemption": false,
"start_date": "2024-04-19",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06964152",
"publication_url": "https://clinicaltrials.gov/study/NCT06964152",
"title": "Prospective Use of Computational Cardiac Imaging Analysis to Guide Ventricular Tachycardia Ablation Procedures (AI-VT)",
"has_exemption": false,
"start_date": "2024-05-01",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Diego",
"sponsor_slug": "university-of-california-san-diego",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06200103",
"publication_url": "https://clinicaltrials.gov/study/NCT06200103",
"title": "Minority-Inclusive Imaging Biomarker-Based End of Therapy Trial for 177Lu-PSMA-617, a Randomized De-Escalation Theranostic Trial for Metastatic Castrate Resistant Prostate Cancer",
"has_exemption": false,
"start_date": "2024-05-03",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06395402",
"publication_url": "https://clinicaltrials.gov/study/NCT06395402",
"title": "177Lu-DOTATATE Modified Delivery Based on Individualized Dosimetry",
"has_exemption": false,
"start_date": "2024-05-03",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Iowa",
"sponsor_slug": "university-of-iowa",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06207799",
"publication_url": "https://clinicaltrials.gov/study/NCT06207799",
"title": "Pre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With High-risk Multiple Myeloma",
"has_exemption": false,
"start_date": "2024-07-17",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06526338",
"publication_url": "https://clinicaltrials.gov/study/NCT06526338",
"title": "A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of IP-001 as Adjuvant Therapy in Participants With Hepatocellular Carcinoma After Complete Radiological Response After Surgical Resection and Local Ablation or Local Ablation Alone",
"has_exemption": false,
"start_date": "2024-07-24",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Robert C. Martin",
"sponsor_slug": "robert-c-martin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06107764",
"publication_url": "https://clinicaltrials.gov/study/NCT06107764",
"title": "Cerebellar Modulation of Cognition in Psychosis",
"has_exemption": false,
"start_date": "2024-07-31",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mclean Hospital",
"sponsor_slug": "mclean-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06445946",
"publication_url": "https://clinicaltrials.gov/study/NCT06445946",
"title": "DECIDE: A Comparative Effectiveness Trial of Oral Metformin Versus Injectable Insulin for the Treatment of Gestational Diabetes",
"has_exemption": false,
"start_date": "2024-08-01",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ohio State University",
"sponsor_slug": "ohio-state-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06061809",
"publication_url": "https://clinicaltrials.gov/study/NCT06061809",
"title": "Open-Label, Single-Arm Phase 2 Study of Nogapendekin Alfa Inbakicept, PD-L1 t-haNK, Bevacizumab and Randomized Phase 2B Study of Nogapendekin Alfa Inbakicept, Bevacizumab, and Tumor Treatment Fields With or Without PD-L1 t-haNK in Participants With Recurrent or Progressive Glioblastoma",
"has_exemption": false,
"start_date": "2024-08-07",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "ImmunityBio, Inc.",
"sponsor_slug": "immunitybio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06518551",
"publication_url": "https://clinicaltrials.gov/study/NCT06518551",
"title": "A Phase I/II Study of Elotuzumab and Iberdomide and Dexamethasone Post Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma",
"has_exemption": false,
"start_date": "2024-11-01",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Omar Nadeem, MD",
"sponsor_slug": "omar-nadeem-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06575192",
"publication_url": "https://clinicaltrials.gov/study/NCT06575192",
"title": "A Prospective, Multicenter, Open-Label, Non-Randomized, Controlled Pivotal Study to Evaluate the Safety and Effectiveness of ARTIA Reconstructive Tissue Matrix in Implant-Based Two Stage Prepectoral Breast Reconstruction Post-Mastectomy",
"has_exemption": false,
"start_date": "2024-11-05",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06500975",
"publication_url": "https://clinicaltrials.gov/study/NCT06500975",
"title": "Long Term Outcomes After Vestibular Implantation",
"has_exemption": false,
"start_date": "2024-12-01",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06735976",
"publication_url": "https://clinicaltrials.gov/study/NCT06735976",
"title": "Efficacy & Safety of LOBO™ Vascular Occlusion Device for Embolization of Pulmonary Arteriovenous Malformations (PAVM)",
"has_exemption": false,
"start_date": "2024-12-17",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of North Carolina, Chapel Hill",
"sponsor_slug": "university-of-north-carolina-chapel-hill",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06711705",
"publication_url": "https://clinicaltrials.gov/study/NCT06711705",
"title": "Phase II MRD-Adapted Study of Elranatamab in Relapsed/Refractory",
"has_exemption": false,
"start_date": "2024-12-18",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Diego",
"sponsor_slug": "university-of-california-san-diego",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05213676",
"publication_url": "https://clinicaltrials.gov/study/NCT05213676",
"title": "Inhaled Nitric Oxide (iNO) for Congenital Diaphragmatic Hernia (CDH) - The \"NoNO Trial\" - a Multi-center, De-implementation, Stepped-wedge, Cluster-randomized Trial Within an Established Collaborative",
"has_exemption": false,
"start_date": "2025-01-01",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center, Houston",
"sponsor_slug": "the-university-of-texas-health-science-center-houston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06769633",
"publication_url": "https://clinicaltrials.gov/study/NCT06769633",
"title": "A Phase 2 Open-label (Core Phase Plus Extension Phase) With 2 Cohorts Study to Assess the Pharmacokinetics and Safety of Givinostat in DMD Patients Ages From at Least 2 Years to Less Than 6 Years Old",
"has_exemption": false,
"start_date": "2025-01-02",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Italfarmaco",
"sponsor_slug": "italfarmaco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05669846",
"publication_url": "https://clinicaltrials.gov/study/NCT05669846",
"title": "Phase II Feasibility Study of Healthy Donor FMT (hdFMT) and Pembrolizumab in Relapsed/Refractory (R/R) PD-L1 Positive NSCLC",
"has_exemption": false,
"start_date": "2025-01-08",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Diwakar Davar",
"sponsor_slug": "diwakar-davar",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06132178",
"publication_url": "https://clinicaltrials.gov/study/NCT06132178",
"title": "Assessing the Safety, Tolerability, and Efficacy of Psilocybin Therapy Followed by Accelerated Intermittent Theta Burst (aiTBS) Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment-Resistant Major Depressive Disorder",
"has_exemption": false,
"start_date": "2025-01-10",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas at Austin",
"sponsor_slug": "university-of-texas-at-austin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06797635",
"publication_url": "https://clinicaltrials.gov/study/NCT06797635",
"title": "An Open-label Randomized Phase 2 Study to Evaluate Safety and Efficacy of Patritumab Deruxtecan Plus Pembrolizumab Administered Either Before or After Carboplatin/Paclitaxel Plus Pembrolizumab Compared With Pembrolizumab in Combination With Chemotherapy Followed by Surgery and Adjuvant Pembrolizumab for High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer (HERTHENA-Breast03)",
"has_exemption": false,
"start_date": "2025-03-20",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05766839",
"publication_url": "https://clinicaltrials.gov/study/NCT05766839",
"title": "A 2-Part, Open-Label, Phase 2, Multiple Dose Study to Evaluate the Pharmacodynamic Effects, Safety, and Tolerability of Patiromer in Children Under 12 Years of Age With Hyperkalaemia (EMERALD2)",
"has_exemption": false,
"start_date": "2025-04-06",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Vifor Pharma, Inc.",
"sponsor_slug": "vifor-pharma-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07064018",
"publication_url": "https://clinicaltrials.gov/study/NCT07064018",
"title": "Phase Ib/IIa Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies",
"has_exemption": false,
"start_date": "2025-04-30",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Irvine",
"sponsor_slug": "university-of-california-irvine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07003425",
"publication_url": "https://clinicaltrials.gov/study/NCT07003425",
"title": "A Long-term Extension Study to Evaluate the Safety and Efficacy of APG777 in Patients With Atopic Dermatitis Previously Treated With APG777",
"has_exemption": false,
"start_date": "2025-05-14",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Apogee Therapeutics, Inc.",
"sponsor_slug": "apogee-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06736171",
"publication_url": "https://clinicaltrials.gov/study/NCT06736171",
"title": "Prescription of Robotic Exoskeletons for Ambulation Recovery Post Stroke",
"has_exemption": false,
"start_date": "2025-05-15",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Kessler Foundation",
"sponsor_slug": "kessler-foundation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06901531",
"publication_url": "https://clinicaltrials.gov/study/NCT06901531",
"title": "A Phase 3, Double-blind, Randomized Study of Zolbetuximab in Combination With Pembrolizumab and Chemotherapy (CAPOX or mFOLFOX6) in First-line Treatment of Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma in Participants Whose Tumors Are HER2-negative, Claudin (CLDN) 18.2-positive and Programmed Death-ligand 1 (PD-L1)-Positive",
"has_exemption": false,
"start_date": "2025-05-22",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Astellas Pharma Global Development, Inc.",
"sponsor_slug": "astellas-pharma-global-development-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06976801",
"publication_url": "https://clinicaltrials.gov/study/NCT06976801",
"title": "Prospective, Randomized-control Trial Comparing Standard Intramedullary Tibial Fixation With Micromotion Tibial Intramedullary Fixation",
"has_exemption": false,
"start_date": "2025-07-01",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06765109",
"publication_url": "https://clinicaltrials.gov/study/NCT06765109",
"title": "A Phase 3 Study of the Selective Anaplastic Lymphoma Kinase (ALK) Inhibitor NVL-655 Compared to Alectinib in First-Line Treatment of Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer (ALKAZAR)",
"has_exemption": false,
"start_date": "2025-07-17",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Nuvalent Inc.",
"sponsor_slug": "nuvalent-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06508931",
"publication_url": "https://clinicaltrials.gov/study/NCT06508931",
"title": "A Single-arm, Multi-center, Open-label Phase II Study to Determine the Safety and Efficacy of MB-CART2019.1 in Pediatric Subjects With Relapsed/Refractory Mature B-cell Neoplasms Who Have Relapsed After One or More Prior Therapies, Including Subjects With Primary Refractory Disease",
"has_exemption": false,
"start_date": "2025-08-04",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Miltenyi Biomedicine GmbH",
"sponsor_slug": "miltenyi-biomedicine-gmbh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06740968",
"publication_url": "https://clinicaltrials.gov/study/NCT06740968",
"title": "Improving Neural Oscillation and Synchrony Between Motor and Auditory Regions in Stuttering Using Personalized Transcranial Alternating Current Stimulation (tACS)",
"has_exemption": false,
"start_date": "2025-08-05",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan",
"sponsor_slug": "university-of-michigan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06561074",
"publication_url": "https://clinicaltrials.gov/study/NCT06561074",
"title": "A Phase 2 Study to Evaluate Efficacy of Calaspargase Pegol-mknl and Decitabine Combined With Venetoclax in Pediatric, Adolescent, and Young Adult Patients With Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia (T-ALL) and T- Cell Lymphoblastic Lymphoma (T-LLy)",
"has_exemption": false,
"start_date": "2025-09-25",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07144813",
"publication_url": "https://clinicaltrials.gov/study/NCT07144813",
"title": "Clinical Post- Approval Study of the Neuspera Sacral Neuromodulation (SNM) System in Patients With Symptoms of Urinary Urgency Incontinence (UUI)",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Neuspera Medical, Inc.",
"sponsor_slug": "neuspera-medical-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07173751",
"publication_url": "https://clinicaltrials.gov/study/NCT07173751",
"title": "A Phase III, Multisite, Randomized, Double-Blind Trial of BNT327 in Combination With Chemotherapy Versus Placebo With Chemotherapy in Patients With Previously Untreated Locally Recurrent Inoperable or Metastatic TNBC Determined Ineligible for PD(L)1 Therapy Based on PD-L1 Negative Disease",
"has_exemption": false,
"start_date": "2025-10-30",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Biontech SE",
"sponsor_slug": "biontech-se",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07188532",
"publication_url": "https://clinicaltrials.gov/study/NCT07188532",
"title": "Biologically-Adapted, Dose-Escalated Accelerated Radiotherapy for Ewing Sarcoma (BEAR)",
"has_exemption": false,
"start_date": "2025-11-24",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06854029",
"publication_url": "https://clinicaltrials.gov/study/NCT06854029",
"title": "Optimizing Long-Acting Pre-Exposure Prophylaxis and Medications for Opioid Use Disorder Interventions in Carceral Settings",
"has_exemption": false,
"start_date": "2025-11-30",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07214376",
"publication_url": "https://clinicaltrials.gov/study/NCT07214376",
"title": "A Randomized Placebo-procedure Controlled Trial of the Multi-Pole Pulmonary Artery Radiofrequency Ablation Enhancor System PULmonary Artery Denervation Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Pulnovo Medical, Inc.",
"sponsor_slug": "pulnovo-medical-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07216391",
"publication_url": "https://clinicaltrials.gov/study/NCT07216391",
"title": "Adaptive Platform Trial to Delay Progression From Stage 2 to Stage 3 Type 1 Diabetes: Comparing Teplizumab With Low-dose Anti-Thymocyte Globulin (ATG) Protocol TN-40A",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
"sponsor_slug": "national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07283367",
"publication_url": "https://clinicaltrials.gov/study/NCT07283367",
"title": "A Phase Ib/II Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of HS-20110 Combination Therapies in Patients With Advanced Colorectal Cancer.",
"has_exemption": false,
"start_date": "2025-12-19",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Hansoh BioMedical R&D Company",
"sponsor_slug": "hansoh-biomedical-rd-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07220915",
"publication_url": "https://clinicaltrials.gov/study/NCT07220915",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Panzyga for Prevention of Major Infection in Patients With Hypogammaglobulinemia and Autoimmune or Rheumatic Conditions Receiving Treatment With B-cell Depletion Therapy (\"PROTECT\")",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Octapharma",
"sponsor_slug": "octapharma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07112105",
"publication_url": "https://clinicaltrials.gov/study/NCT07112105",
"title": "Repetitive Transcranial Magnetic Stimulation Treatment of Stimulant Use Disorder",
"has_exemption": false,
"start_date": "2026-01-01",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07223190",
"publication_url": "https://clinicaltrials.gov/study/NCT07223190",
"title": "A Phase 3, Open-label, Randomized, Controlled Trial of Subcutaneous Versus Intravenous Blinatumomab in Newly Diagnosed Adults With Philadelphia Chromosome Negative B-cell Precursor Acute Lymphoblastic Leukaemia",
"has_exemption": false,
"start_date": "2026-01-30",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07060638",
"publication_url": "https://clinicaltrials.gov/study/NCT07060638",
"title": "Integrated Therapies for Alcohol Use in Alcohol-associated Liver Disease (ITAALD) Trial",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Samer Gawrieh",
"sponsor_slug": "samer-gawrieh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07112196",
"publication_url": "https://clinicaltrials.gov/study/NCT07112196",
"title": "Adaptive, Phase 2/3, Randomized, Double-Blind Trial Investigating the Efficacy and Safety of Visugromab Versus Placebo in Patients With Cancer-associated Cachexia",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "CatalYm GmbH",
"sponsor_slug": "catalym-gmbh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07188558",
"publication_url": "https://clinicaltrials.gov/study/NCT07188558",
"title": "A Phase 3 Randomized Controlled Trial of Rondecabtagene Autoleucel , an Autologous, Dual-targeting CD19/CD20 CAR T-Cell Product Candidate, Vs. Investigator's Choice of CD19 CAR T-Cell Therapy in Patients With Relapsed or Refractory Large B-Cell Lymphoma in the Second-line Setting",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Lyell Immunopharma, Inc.",
"sponsor_slug": "lyell-immunopharma-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07027969",
"publication_url": "https://clinicaltrials.gov/study/NCT07027969",
"title": "Efficacy of Cardiometabolic Risk Factor Control Through Metabolic Surgery on Management and Severity of Atrial Fibrillation: METSAFE Randomized Clinical Trial",
"has_exemption": false,
"start_date": "2026-02-01",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ali Aminian",
"sponsor_slug": "ali-aminian",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06681220",
"publication_url": "https://clinicaltrials.gov/study/NCT06681220",
"title": "Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC",
"has_exemption": false,
"start_date": "2026-02-23",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07162480",
"publication_url": "https://clinicaltrials.gov/study/NCT07162480",
"title": "Phase II Trial of Puxitatug Samrotecan (AZD8205) in Advanced, Recurrent or Metastatic (R/M) Aggressive Adenoid Cystic Carcinoma Subtype I (ACC-I)",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07258771",
"publication_url": "https://clinicaltrials.gov/study/NCT07258771",
"title": "Acute Severe Ulcerative Colitis- Upadacitinib Combined With Corticosteroids vs Corticosteroid Monotherapy Induction While Transitioning Away From the Emergency Setting (ACUTE): A Phase IV, Single Center, Partially Blinded, Randomized Study",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Berinstein, Jeffrey",
"sponsor_slug": "berinstein-jeffrey",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07308938",
"publication_url": "https://clinicaltrials.gov/study/NCT07308938",
"title": "Trial of Topical Fluorometholone as Adjunctive Therapy for Bacterial Corneal Ulcers",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Vishal Jhanji",
"sponsor_slug": "vishal-jhanji",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07300982",
"publication_url": "https://clinicaltrials.gov/study/NCT07300982",
"title": "Studies of Insulin and Glucagon Action in the Liver",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05494697",
"publication_url": "https://clinicaltrials.gov/study/NCT05494697",
"title": "A Phase 2 Randomized Open-Label Controlled Study to Evaluate the Efficacy and Safety of Ampligen in Combination With Standard of Care Versus SOC Alone Following First-Line Therapy in Subjects With Locally Advanced Pancreatic Adenocarcinoma",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AIM ImmunoTech Inc.",
"sponsor_slug": "aim-immunotech-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07285148",
"publication_url": "https://clinicaltrials.gov/study/NCT07285148",
"title": "An Open-label, Multicenter Phase Ib/II Study to Evaluate the Safety, Efficacy and Pharmacokinetic Characteristics of ANS014004 in Combination With EGFR-TKI in Patients With EGFR Mutation-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Beijing Pearl Biotechnology Limited Liability Company",
"sponsor_slug": "beijing-pearl-biotechnology-limited-liability-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02864888",
"publication_url": "https://clinicaltrials.gov/study/NCT02864888",
"title": "A Controlled, Study of the Effect of Combination Antineoplaston Therapy [Atengenal (A10) and Astugenal (AS2-1)] on the QT/QTc Interval In Subjects With Newly Diagnosed Diffuse, Intrinsic, Brainstem Glioma",
"has_exemption": false,
"start_date": "2027-06-30",
"completion_date": "2029-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Burzynski Research Institute",
"sponsor_slug": "burzynski-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03206060",
"publication_url": "https://clinicaltrials.gov/study/NCT03206060",
"title": "Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma",
"has_exemption": false,
"start_date": "2017-10-10",
"completion_date": "2030-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04337515",
"publication_url": "https://clinicaltrials.gov/study/NCT04337515",
"title": "A Feasibility Study of Using the CiniMacs® Device for Alpha/Best T-Cell Depletion in Stem Cell Transplant Recipients",
"has_exemption": false,
"start_date": "2019-12-19",
"completion_date": "2030-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Christopher Dvorak",
"sponsor_slug": "christopher-dvorak",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05088798",
"publication_url": "https://clinicaltrials.gov/study/NCT05088798",
"title": "Use of18F-DOPA PET/MRI for the Detection and Localization of Focal Forms of Hyperinsulinism",
"has_exemption": false,
"start_date": "2020-09-10",
"completion_date": "2030-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02773082",
"publication_url": "https://clinicaltrials.gov/study/NCT02773082",
"title": "Reclaim™ Deep Brain Stimulation (DBS) Therapy for Obsessive-Compulsive Disorder (OCD)",
"has_exemption": false,
"start_date": "2024-07-06",
"completion_date": "2030-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwell Health",
"sponsor_slug": "northwell-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06068543",
"publication_url": "https://clinicaltrials.gov/study/NCT06068543",
"title": "A Phase 2 Randomized Controlled Trial of Epigallocatechin-3-Gallate (EGCG) on Frailty and Inflammation in Older Survivors of Cancer",
"has_exemption": false,
"start_date": "2024-09-30",
"completion_date": "2030-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Rochester",
"sponsor_slug": "university-of-rochester",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07010146",
"publication_url": "https://clinicaltrials.gov/study/NCT07010146",
"title": "Role of Estrogen Formulation and Route of Delivery on Skeletal Outcomes in Functional Hypothalmic Amenorrhea",
"has_exemption": false,
"start_date": "2025-07-01",
"completion_date": "2030-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Virginia",
"sponsor_slug": "university-of-virginia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07043972",
"publication_url": "https://clinicaltrials.gov/study/NCT07043972",
"title": "Phase II Study of Second-line Gemcitabine Plus Carboplatin After Progression on Enfortumab Vedotin With Pembrolizumab in Advanced or Metastatic Urothelial Carcinoma",
"has_exemption": false,
"start_date": "2025-07-09",
"completion_date": "2030-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Fox Chase Cancer Center",
"sponsor_slug": "fox-chase-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06440707",
"publication_url": "https://clinicaltrials.gov/study/NCT06440707",
"title": "Transcranial Electrical Stimulation in Stroke EaRly After Onset Clinical Trial 2",
"has_exemption": false,
"start_date": "2025-07-15",
"completion_date": "2030-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Los Angeles",
"sponsor_slug": "university-of-california-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07300865",
"publication_url": "https://clinicaltrials.gov/study/NCT07300865",
"title": "Does the Thickness of the Gastrostomy Affect the Incidence of Complications? A Prospective Randomized Single-Center Study in Children",
"has_exemption": false,
"start_date": "2025-11-20",
"completion_date": "2030-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Therese Hössjer",
"sponsor_slug": "therese-hossjer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07220252",
"publication_url": "https://clinicaltrials.gov/study/NCT07220252",
"title": "Ublituximab in Pediatric Participants With Relapsing Forms of Multiple Sclerosis (RMS)",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2030-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "TG Therapeutics, Inc.",
"sponsor_slug": "tg-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06303193",
"publication_url": "https://clinicaltrials.gov/study/NCT06303193",
"title": "Phase I/II Trial of Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms",
"has_exemption": false,
"start_date": "2026-02-01",
"completion_date": "2030-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06214793",
"publication_url": "https://clinicaltrials.gov/study/NCT06214793",
"title": "A Phase II Study of Taletrectinib in Previously Treated Metastatic CDH1-mutated Invasive Lobular Cancer (ILC) of the Breast (TaCe)",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2030-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Megan Kruse, MD",
"sponsor_slug": "megan-kruse-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07213674",
"publication_url": "https://clinicaltrials.gov/study/NCT07213674",
"title": "A Phase 3, Open-label, Multicenter, Randomized Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer",
"has_exemption": false,
"start_date": "2025-11-28",
"completion_date": "2030-01-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07335796",
"publication_url": "https://clinicaltrials.gov/study/NCT07335796",
"title": "A Phase 2 Study of Androgen Deprivation Therapy and BMS986365 in High-Risk Localized Prostate Cancer Patients Prior to Radical Prostatectomy",
"has_exemption": false,
"start_date": "2026-01-09",
"completion_date": "2030-01-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07167940",
"publication_url": "https://clinicaltrials.gov/study/NCT07167940",
"title": "RAPID5: Rapid Acceleration Process for Intensive Treatment of PTSD in 5 Days",
"has_exemption": false,
"start_date": "2026-03-09",
"completion_date": "2030-01-09",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05454306",
"publication_url": "https://clinicaltrials.gov/study/NCT05454306",
"title": "The Anser Clavicle Pin for Surgical Management of Midshaft Clavicle Fractures; A U.S. Prospective Case Series",
"has_exemption": false,
"start_date": "2028-01-09",
"completion_date": "2030-01-09",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06853665",
"publication_url": "https://clinicaltrials.gov/study/NCT06853665",
"title": "A Pharmaco-Imaging Trial of Mixed Amphetamine Salts for the Treatment of ADHD in Intellectually-intact Youth With Autism Spectrum Disorder",
"has_exemption": false,
"start_date": "2026-01-10",
"completion_date": "2030-01-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Gagan Joshi",
"sponsor_slug": "gagan-joshi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT00109174",
"publication_url": "https://clinicaltrials.gov/study/NCT00109174",
"title": "MRS (Magnetic Resonance Spectroscopy) Measurement of Glutamate and GABA Metabolism in Brain",
"has_exemption": false,
"start_date": "2006-09-06",
"completion_date": "2030-01-11",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Mental Health (NIMH)",
"sponsor_slug": "national-institute-of-mental-health-nimh",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT05800015",
"publication_url": "https://clinicaltrials.gov/study/NCT05800015",
"title": "A Randomized, Double-Blind Phase 2/3 Study of Fianlimab (Anti-LAG-3 Antibody), Cemiplimab (Anti-PD-1 Antibody), and Chemotherapy Versus Cemiplimab and Chemotherapy in First-Line Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Irrespective of PD-L1 Expression Levels",
"has_exemption": false,
"start_date": "2023-08-08",
"completion_date": "2030-01-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07286266",
"publication_url": "https://clinicaltrials.gov/study/NCT07286266",
"title": "A Randomized, Open-label, Multicenter, Phase 3 Study to Investigate GSK5733584 Compared With Chemotherapy in Participants With Platinum-resistant Ovarian Cancer",
"has_exemption": false,
"start_date": "2026-03-03",
"completion_date": "2030-01-16",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01687608",
"publication_url": "https://clinicaltrials.gov/study/NCT01687608",
"title": "A Phase 1/2 Open-Label, Single Ascending Dose Trial of a Self-Complementing Optimized Adeno-associated Virus Serotype 8 Factor IX Gene Therapy (AskBio009) in Adults With Hemophilia B",
"has_exemption": false,
"start_date": "2013-02-11",
"completion_date": "2030-01-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Baxalta now part of Shire",
"sponsor_slug": "baxalta-now-part-of-shire",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT06868277",
"publication_url": "https://clinicaltrials.gov/study/NCT06868277",
"title": "A Phase III, Randomized, Double-blind, Multicenter, Global Study of Rilvegostomig or Pembrolizumab Monotherapy for the First-line Treatment of Patients With PD-L1-high Metastatic Non-small Cell Lung Cancer (ARTEMIDE-Lung04)",
"has_exemption": false,
"start_date": "2025-04-10",
"completion_date": "2030-01-17",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06572605",
"publication_url": "https://clinicaltrials.gov/study/NCT06572605",
"title": "A Phase 1b/2 Study of Talquetamab Plus Concomitant Priming Radiotherapy in Multiple Myeloma With Extramedullary Disease",
"has_exemption": false,
"start_date": "2025-08-29",
"completion_date": "2030-01-18",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04638647",
"publication_url": "https://clinicaltrials.gov/study/NCT04638647",
"title": "An Open-label, Multi-center Protocol for Patients Who Have Completed a Previous Novartis Sponsored Secukinumab Study and Are Judged by the Investigator to Benefit From Continued Secukinumab Treatment",
"has_exemption": false,
"start_date": "2020-12-22",
"completion_date": "2030-01-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06909825",
"publication_url": "https://clinicaltrials.gov/study/NCT06909825",
"title": "A Phase 2, Open-label, Multi-centre Study of FPI-2265 (225Ac-PSMA-I&T) and Olaparib in Participants With Metastatic Castration Resistant Prostate Cancer (mCRPC)",
"has_exemption": false,
"start_date": "2025-02-26",
"completion_date": "2030-01-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Fusion Pharmaceuticals Inc.",
"sponsor_slug": "fusion-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04008368",
"publication_url": "https://clinicaltrials.gov/study/NCT04008368",
"title": "Repeat Peripheral Blood Stem Cell Transplantation for Patients With Sickle Cell Disease or Beta-Thalassemia and Falling Donor Myeloid Chimerism Levels",
"has_exemption": false,
"start_date": "2019-10-24",
"completion_date": "2030-01-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Heart, Lung, and Blood Institute (NHLBI)",
"sponsor_slug": "national-heart-lung-and-blood-institute-nhlbi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05464719",
"publication_url": "https://clinicaltrials.gov/study/NCT05464719",
"title": "A Phase II Study of Loncastuximab Tesirine as Consolidation Strategy in Patients With LBCL in PR After CAR T-cell Therapy",
"has_exemption": false,
"start_date": "2022-09-23",
"completion_date": "2030-01-30",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06205485",
"publication_url": "https://clinicaltrials.gov/study/NCT06205485",
"title": "A Phase 3 Randomized Trial Of Neoadjuvant Chemotherapy, Excision And Observation Versus Chemoradiotherapy For Early Rectal Cancer",
"has_exemption": false,
"start_date": "2024-06-26",
"completion_date": "2030-01-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Canadian Cancer Trials Group",
"sponsor_slug": "canadian-cancer-trials-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06846281",
"publication_url": "https://clinicaltrials.gov/study/NCT06846281",
"title": "A Randomized, Open-label, Parallel-group, Non-inferiority Study Comparing Efficacy, Safety, and Tolerability of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis, Followed by Open-label Treatment With Remibrutinib",
"has_exemption": false,
"start_date": "2025-07-23",
"completion_date": "2030-01-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT00785525",
"publication_url": "https://clinicaltrials.gov/study/NCT00785525",
"title": "Filgrastim-Mobilized Peripheral Blood Stem Cells for Allogeneic Transplantation With Unrelated Donors",
"has_exemption": false,
"start_date": "1997-02-28",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Center for International Blood and Marrow Transplant Research",
"sponsor_slug": "center-for-international-blood-and-marrow-transplant-research",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02605785",
"publication_url": "https://clinicaltrials.gov/study/NCT02605785",
"title": "A Molecular Anatomic Imaging Analysis of Tau in Progressive Supranuclear Palsy",
"has_exemption": false,
"start_date": "2015-11-30",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03599752",
"publication_url": "https://clinicaltrials.gov/study/NCT03599752",
"title": "The Role of Multimodality Management in Risk-Stratified Patients With Lung-Limited Metastatic Colorectal Cancer",
"has_exemption": false,
"start_date": "2018-07-02",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03801083",
"publication_url": "https://clinicaltrials.gov/study/NCT03801083",
"title": "A Phase 2 Study to Evaluate the Efficacy and Safety of Adoptive Transfer of Autologous Tumor Infiltrating Lymphocytes in Patients With Locally Advanced, Recurrent, or Metastatic Biliary Tract Cancers",
"has_exemption": false,
"start_date": "2019-02-19",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Udai Kammula",
"sponsor_slug": "udai-kammula",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04375722",
"publication_url": "https://clinicaltrials.gov/study/NCT04375722",
"title": "Exogenous Tuning of Neural Oscillations as a Mode of Treatment in Post-stroke Aphasia",
"has_exemption": false,
"start_date": "2020-01-04",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05030441",
"publication_url": "https://clinicaltrials.gov/study/NCT05030441",
"title": "A Pilot Study of Ivosidenib for Patients With Clonal Cytopenia of Undetermined Significance and Mutations in IDH1",
"has_exemption": false,
"start_date": "2022-04-01",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05554302",
"publication_url": "https://clinicaltrials.gov/study/NCT05554302",
"title": "Characterization of 18F-Fluciclovine PET Amino Acid Radiotracer in Resected Brain Metastasis",
"has_exemption": false,
"start_date": "2023-01-10",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Baptist Health South Florida",
"sponsor_slug": "baptist-health-south-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05643742",
"publication_url": "https://clinicaltrials.gov/study/NCT05643742",
"title": "A Phase 1/2, Open-Label, Multicenter, Dose Escalation and Cohort Expansion Study of the Safety and Efficacy of Anti-CD19 Allogeneic CRISPR-Cas9-Engineered T Cells (CTX112) in Subjects With Relapsed or Refractory B Cell Malignancies",
"has_exemption": false,
"start_date": "2023-03-10",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "CRISPR Therapeutics AG",
"sponsor_slug": "crispr-therapeutics-ag",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06193551",
"publication_url": "https://clinicaltrials.gov/study/NCT06193551",
"title": "Ovitex in Paraesophageal and Large Hiatal Hernia Repair. (OviPHeR)",
"has_exemption": false,
"start_date": "2024-02-19",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Foregut Research Foundation",
"sponsor_slug": "foregut-research-foundation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06412666",
"publication_url": "https://clinicaltrials.gov/study/NCT06412666",
"title": "A Phase 2/3 Multicenter, Randomized, Double-Blind, Placebo-Controlled and Open-Label Extension Trial to Evaluate the Efficacy and Safety of Aficamten in a Pediatric Population With Symptomatic Obstructive Hypertrophic Cardiomyopathy",
"has_exemption": false,
"start_date": "2024-05-29",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Cytokinetics",
"sponsor_slug": "cytokinetics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06559176",
"publication_url": "https://clinicaltrials.gov/study/NCT06559176",
"title": "A Phase 1/2 Study Evaluating Gene Therapy by Transplantation of Autologous CD34+ Stem Cells Modified Ex Vivo Using Prime Editing (PM359) in Participants With Autosomal Recessive Chronic Granulomatous Disease Due to Mutations in the NCF1 Gene",
"has_exemption": false,
"start_date": "2024-10-17",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Prime Medicine, Inc.",
"sponsor_slug": "prime-medicine-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06857773",
"publication_url": "https://clinicaltrials.gov/study/NCT06857773",
"title": "Hepatic Arterial Infusion PUMP Chemotherapy Combined With Systemic Therapy Versus Systemic Therapy Alone as Induction Therapy for Initially Unresectable Colorectal Liver Metastases: a Randomised Controlled Trial",
"has_exemption": false,
"start_date": "2024-11-21",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "The Netherlands Cancer Institute",
"sponsor_slug": "the-netherlands-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06581406",
"publication_url": "https://clinicaltrials.gov/study/NCT06581406",
"title": "A Randomized, Phase 2/3, Open-Label Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab Versus Ipilimumab in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma",
"has_exemption": false,
"start_date": "2024-12-17",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Replimune Inc.",
"sponsor_slug": "replimune-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06607406",
"publication_url": "https://clinicaltrials.gov/study/NCT06607406",
"title": "A Randomized Trial of Accelerated Postoperative Radiotherapy for Intermediate- and High-risk Patients With HNSCC (Head and Neck Squamous Cell Carcinoma) Initiating Radiotherapy Greater Than 6 Weeks After Surgery (PORTRush)",
"has_exemption": false,
"start_date": "2025-01-21",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Wake Forest University Health Sciences",
"sponsor_slug": "wake-forest-university-health-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06781931",
"publication_url": "https://clinicaltrials.gov/study/NCT06781931",
"title": "DG1 Spectacle Lens for Myopia Progression Control in Children: A Three-year Multicenter, Prospective, Randomized, Double-masked, Controlled Clinical Trial to Evaluate the Efficacy and Safety Followed by a One-year Rebound Evaluation",
"has_exemption": false,
"start_date": "2025-01-21",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "HOYA Lens Thailand LTD.",
"sponsor_slug": "hoya-lens-thailand-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06842355",
"publication_url": "https://clinicaltrials.gov/study/NCT06842355",
"title": "A Multicenter, Phase 2, Dose-Escalation/Dose-Expansion Study of TYRA-300 in Children With Achondroplasia With Open Growth Plates: BEACH301",
"has_exemption": false,
"start_date": "2025-03-04",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Tyra Biosciences, Inc",
"sponsor_slug": "tyra-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06717438",
"publication_url": "https://clinicaltrials.gov/study/NCT06717438",
"title": "A Phase 2 Randomized, Double-blind, Placebo-controlled, Study of Zatolmilast (BPN14770) in Subjects With PPP2R5D Neurodevelopmental Disorder (Jordan's Syndrome)",
"has_exemption": false,
"start_date": "2025-05-13",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Shionogi",
"sponsor_slug": "shionogi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06745882",
"publication_url": "https://clinicaltrials.gov/study/NCT06745882",
"title": "Prospective Trial to Assess Real-world Outcomes and Predictive Biomarkers of Response to Pembrolizumab With or Without Chemotherapy in Black Patients With NSCLC",
"has_exemption": false,
"start_date": "2025-06-13",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lee Moffitt Cancer Center and Research Institute",
"sponsor_slug": "h-lee-moffitt-cancer-center-and-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07076225",
"publication_url": "https://clinicaltrials.gov/study/NCT07076225",
"title": "A Ultrashort Regimen for Drug-susceptible Pulmonary Tuberculosis in Elderly Patients: A Multicenter Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2025-07-25",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Shenzhen Third People's Hospital",
"sponsor_slug": "shenzhen-third-peoples-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07213661",
"publication_url": "https://clinicaltrials.gov/study/NCT07213661",
"title": "Long-term Comparative Effectiveness of 2 Treatments to Arrest Dental Caries in Older Adults",
"has_exemption": false,
"start_date": "2025-10-08",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Case Western Reserve University",
"sponsor_slug": "case-western-reserve-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07157254",
"publication_url": "https://clinicaltrials.gov/study/NCT07157254",
"title": "A Phase 2, Open-label, Basket Study Investigating the Safety and Efficacy of GTX-102 in Adult and Pediatric Subjects With Deletion- or Nondeletion-type Angelman Syndrome",
"has_exemption": false,
"start_date": "2025-10-13",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ultragenyx Pharmaceutical Inc",
"sponsor_slug": "ultragenyx-pharmaceutical-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06200259",
"publication_url": "https://clinicaltrials.gov/study/NCT06200259",
"title": "Reduction of Gastrointestinal Toxicity in Prostate Cancer by Proton Spot Placement",
"has_exemption": false,
"start_date": "2025-12-15",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Thompson Cancer Survival Center",
"sponsor_slug": "thompson-cancer-survival-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07129473",
"publication_url": "https://clinicaltrials.gov/study/NCT07129473",
"title": "Hyperemesis Gravidarum Risk Reduction With Metformin",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Southern California",
"sponsor_slug": "university-of-southern-california",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07223307",
"publication_url": "https://clinicaltrials.gov/study/NCT07223307",
"title": "Phase II Trial of REal Time MRI GUided Adaptive Stereotactic Ablative Radiotherapy for Liver Cancers Using a Single Session, Simulation Free Workflow",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07288151",
"publication_url": "https://clinicaltrials.gov/study/NCT07288151",
"title": "MDMA-Assisted Massed Exposure Therapy for PTSD",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07303946",
"publication_url": "https://clinicaltrials.gov/study/NCT07303946",
"title": "Double-Blind, Crossover, Feasibility Study of Deep Brain Stimulation of the Anterior Cingulate Bundle (ACB) and the Ventral Anterior Limb of the Internal Capsule (vALIC) in Patients With Intractable Obsessive Compulsive Disorder (OCD)",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Rhode Island Hospital",
"sponsor_slug": "rhode-island-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07280468",
"publication_url": "https://clinicaltrials.gov/study/NCT07280468",
"title": "Endotype DIrected Treatment for OSA in Down Syndrome",
"has_exemption": false,
"start_date": "2026-02-01",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Arizona",
"sponsor_slug": "university-of-arizona",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07328503",
"publication_url": "https://clinicaltrials.gov/study/NCT07328503",
"title": "A Phase II Study to Examine the Impact of CD22 CAR T-cells to Extend the Duration of Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia",
"has_exemption": false,
"start_date": "2026-02-01",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07264920",
"publication_url": "https://clinicaltrials.gov/study/NCT07264920",
"title": "Pediatric Electrocutaneous Analgesia for Children Experiencing Neuropathic Pain",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07332442",
"publication_url": "https://clinicaltrials.gov/study/NCT07332442",
"title": "Continuous Positive Airway Pressure, Arousability and Links to Mechanisms in Obstructive Sleep Apnea",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07369115",
"publication_url": "https://clinicaltrials.gov/study/NCT07369115",
"title": "Intra-Cellular Therapies, Inc. / \"A Randomized, Double-blind, Placebo-controlled, Single Site Study to Evaluate the Efficacy of Lumateperone for the Treatment of Major Depressive Disorder (MDD) and Early Life Trauma in Adult Patients Aged 21 to 70 Years",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas at Austin",
"sponsor_slug": "university-of-texas-at-austin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07050862",
"publication_url": "https://clinicaltrials.gov/study/NCT07050862",
"title": "Circuity-guided Repetitive Transcranial Magnetic Stimulation (rTMS) for Tobacco Use in Veterans: A Comparison of Insula-rTMS and Prefrontal-rTMS",
"has_exemption": false,
"start_date": "2026-04-01",
"completion_date": "2030-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01754363",
"publication_url": "https://clinicaltrials.gov/study/NCT01754363",
"title": "Short, Medium and Long Term Survivorship of Attune Primary Knee Prosthesis",
"has_exemption": false,
"start_date": "2013-02-01",
"completion_date": "2030-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "DePuy International",
"sponsor_slug": "depuy-international",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT04130997",
"publication_url": "https://clinicaltrials.gov/study/NCT04130997",
"title": "An Open Label Extension Study of Ublituximab in Subjects With Relapsing Multiple Sclerosis",
"has_exemption": false,
"start_date": "2019-11-18",
"completion_date": "2030-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "TG Therapeutics, Inc.",
"sponsor_slug": "tg-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07284641",
"publication_url": "https://clinicaltrials.gov/study/NCT07284641",
"title": "Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD)",
"has_exemption": false,
"start_date": "2026-02-01",
"completion_date": "2030-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Paul Szabolcs",
"sponsor_slug": "paul-szabolcs",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07313787",
"publication_url": "https://clinicaltrials.gov/study/NCT07313787",
"title": "Prospective Cross-Over Study of the Effects of Meal Macronutrients on Postprandial Lipids",
"has_exemption": false,
"start_date": "2026-02-01",
"completion_date": "2030-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
"sponsor_slug": "national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07061951",
"publication_url": "https://clinicaltrials.gov/study/NCT07061951",
"title": "A Phase 2 Pilot Study of Mirdametinib in Relapsed Refractory Chronic Lymphocytic Leukemia",
"has_exemption": false,
"start_date": "2026-09-08",
"completion_date": "2030-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07221357",
"publication_url": "https://clinicaltrials.gov/study/NCT07221357",
"title": "ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2030-02-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06413680",
"publication_url": "https://clinicaltrials.gov/study/NCT06413680",
"title": "A Phase 1/2a, Open-Label, Dose Escalation and Dose Expansion First-In-Human Study of the Safety, Tolerability, Activity, and Pharmacokinetics of REGN10597 (Anti-PD-1-IL-2RA-IL-2 Fusion Protein) Alone or in Combination With Cemiplimab in Patients With Advanced Solid Organ Malignancies",
"has_exemption": false,
"start_date": "2024-09-23",
"completion_date": "2030-02-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03309332",
"publication_url": "https://clinicaltrials.gov/study/NCT03309332",
"title": "OSB Lead-AMPLATZER PFO Occluder New Enrollment PAS",
"has_exemption": false,
"start_date": "2018-01-31",
"completion_date": "2030-02-05",
"has_results": false,
"results_due": false,
"sponsor_name": "Abbott Medical Devices",
"sponsor_slug": "abbott-medical-devices",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04528082",
"publication_url": "https://clinicaltrials.gov/study/NCT04528082",
"title": "A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study, Followed by an Active Treatment Phase to Evaluate the Efficacy and Safety of Apremilast in Children From 2 to Less Than 18 Years of Age With Active Oral Ulcers Associated With Behçet's Disease (BEAN)",
"has_exemption": false,
"start_date": "2021-09-09",
"completion_date": "2030-02-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04980872",
"publication_url": "https://clinicaltrials.gov/study/NCT04980872",
"title": "A Multicenter, Open-label, Phase 2, Extension Trial to Study the Long-term Safety in Participants With PROS or Proteus Syndrome Who Are Currently Being Treated With Miransertib in Other Studies",
"has_exemption": false,
"start_date": "2021-11-02",
"completion_date": "2030-02-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06799390",
"publication_url": "https://clinicaltrials.gov/study/NCT06799390",
"title": "Vagus Nerve Stimulation Following Intracerebral Hemorrhage (IHC) to Mitigate ICH-induced Inflammation and Cerebral Edema",
"has_exemption": false,
"start_date": "2025-04-06",
"completion_date": "2030-02-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07204249",
"publication_url": "https://clinicaltrials.gov/study/NCT07204249",
"title": "Glutide for Ending Methamphetamine",
"has_exemption": false,
"start_date": "2026-01-15",
"completion_date": "2030-02-15",
"has_results": false,
"results_due": false,
"sponsor_name": "San Francisco Department of Public Health",
"sponsor_slug": "san-francisco-department-of-public-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06863272",
"publication_url": "https://clinicaltrials.gov/study/NCT06863272",
"title": "MK-2400-01A Substudy: A Phase 1/2, Open-label Umbrella Substudy of MK-2400-U01 Master Protocol to Evaluate the Safety and Efficacy of Ifinatamab Deruxtecan-based Treatment Combinations or Ifinatamab Deruxtecan Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (IDeate-Prostate02)",
"has_exemption": false,
"start_date": "2025-07-03",
"completion_date": "2030-02-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07000149",
"publication_url": "https://clinicaltrials.gov/study/NCT07000149",
"title": "A Phase Ib/III Randomized, Multicenter, Global Study of Volrustomig Plus Casdatifan or Volrustomig Monotherapy Versus Nivolumab Plus Ipilimumab as First-line Treatment for Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)",
"has_exemption": false,
"start_date": "2025-07-28",
"completion_date": "2030-02-21",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04104776",
"publication_url": "https://clinicaltrials.gov/study/NCT04104776",
"title": "A Phase 1/2 Study of DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas",
"has_exemption": false,
"start_date": "2019-09-18",
"completion_date": "2030-02-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT00338377",
"publication_url": "https://clinicaltrials.gov/study/NCT00338377",
"title": "Lymphodepletion Plus Adoptive Cell Transfer With or Without Dendritic Cell Immunization in Patients With Metastatic Melanoma",
"has_exemption": false,
"start_date": "2006-02-01",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT01966367",
"publication_url": "https://clinicaltrials.gov/study/NCT01966367",
"title": "CD34+ Stem Cell Selection for Patients Receiving a Matched or Partially Matched Family or Unrelated Adult Donor Allogeneic Stem Cell Transplantation for Non-Malignant Disease",
"has_exemption": false,
"start_date": "2013-03-31",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Diane George",
"sponsor_slug": "diane-george",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02912312",
"publication_url": "https://clinicaltrials.gov/study/NCT02912312",
"title": "Shortening Adjuvant Photon Irradiation to Reduce Edema (SAPHIRE): A Randomized Trial of Hypofractionated Versus Conventionally Fractionated Regional Nodal Irradiation for Invasive Breast Cancer",
"has_exemption": false,
"start_date": "2017-02-23",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03726554",
"publication_url": "https://clinicaltrials.gov/study/NCT03726554",
"title": "Comprehensive Reverse Shoulder: Porous Augmented Glenoid Baseplate and Mini Humeral Tray Post-Market Clinical Follow-up Study",
"has_exemption": false,
"start_date": "2018-08-28",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Zimmer Biomet",
"sponsor_slug": "zimmer-biomet",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04408352",
"publication_url": "https://clinicaltrials.gov/study/NCT04408352",
"title": "Selective Bladder Denervation Using RF Energy for the Treatment of UUI",
"has_exemption": false,
"start_date": "2020-04-27",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Hologic, Inc.",
"sponsor_slug": "hologic-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04174105",
"publication_url": "https://clinicaltrials.gov/study/NCT04174105",
"title": "A Phase 1/2, Open-Label, Ascending-Dose Clinical Study to Evaluate the Safety and Preliminary Efficacy of AT845, an AAV8-Delivered Gene Transfer Therapy in Patients With Late Onset Pompe Disease",
"has_exemption": false,
"start_date": "2020-10-27",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Astellas Gene Therapies",
"sponsor_slug": "astellas-gene-therapies",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06433635",
"publication_url": "https://clinicaltrials.gov/study/NCT06433635",
"title": "Sequential Multiple Assignment Randomized Trial for Bipolar Depression",
"has_exemption": false,
"start_date": "2024-10-01",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06895785",
"publication_url": "https://clinicaltrials.gov/study/NCT06895785",
"title": "Exalt Single-use Duodenoscope Vs Reusable Scope, a Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2025-02-21",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Rush University Medical Center",
"sponsor_slug": "rush-university-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06839976",
"publication_url": "https://clinicaltrials.gov/study/NCT06839976",
"title": "CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Adolescents and Young Adults With Systemic Lupus Erythematosus (SLE)",
"has_exemption": false,
"start_date": "2025-05-06",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital of Philadelphia",
"sponsor_slug": "childrens-hospital-of-philadelphia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06919666",
"publication_url": "https://clinicaltrials.gov/study/NCT06919666",
"title": "Phase Ib/II Study of NT219 in Combination With Pembrolizumab or Cetuximab in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)",
"has_exemption": false,
"start_date": "2025-06-12",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07003997",
"publication_url": "https://clinicaltrials.gov/study/NCT07003997",
"title": "Janus Kinase (JAK) Signaling in Depression",
"has_exemption": false,
"start_date": "2025-09-03",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07278505",
"publication_url": "https://clinicaltrials.gov/study/NCT07278505",
"title": "Pathophysiological Mechanisms of Cannabidiol in Stress Regulation",
"has_exemption": false,
"start_date": "2025-10-28",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Icahn School of Medicine at Mount Sinai",
"sponsor_slug": "icahn-school-of-medicine-at-mount-sinai",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06890338",
"publication_url": "https://clinicaltrials.gov/study/NCT06890338",
"title": "A Single-Arm, Phase 2 Study of Neoadjuvant Carboplatin and Mirvetuximab Soravtansine in Subjects With FRα-Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer",
"has_exemption": false,
"start_date": "2025-11-21",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06686771",
"publication_url": "https://clinicaltrials.gov/study/NCT06686771",
"title": "Consolidative Use of Radiotherapy to Block (CURB2) Oligoprogression In Patients With Metastatic Non-Small-Cell Lung Cancer",
"has_exemption": false,
"start_date": "2025-12-16",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Canadian Cancer Trials Group",
"sponsor_slug": "canadian-cancer-trials-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06871488",
"publication_url": "https://clinicaltrials.gov/study/NCT06871488",
"title": "Identification of Neural Markers of Aggression and Irritability and Their Capacity to Predict Treatment Response to CNS Stimulant Medication in Youth With ADHD",
"has_exemption": false,
"start_date": "2026-01-15",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Milton S. Hershey Medical Center",
"sponsor_slug": "milton-s-hershey-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07278557",
"publication_url": "https://clinicaltrials.gov/study/NCT07278557",
"title": "Assessment of Sparing Parotid Ducts Via MRI Sialography for Reduced Patient-Reported Xerostomia Following Radiotherapy for Oropharynx Cancer",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "UNC Lineberger Comprehensive Cancer Center",
"sponsor_slug": "unc-lineberger-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07318480",
"publication_url": "https://clinicaltrials.gov/study/NCT07318480",
"title": "Cognitively-enhanced tDCS of the Dorsolateral Prefrontal Cortex to Reduce Craving in Cocaine Addiction",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Icahn School of Medicine at Mount Sinai",
"sponsor_slug": "icahn-school-of-medicine-at-mount-sinai",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07318714",
"publication_url": "https://clinicaltrials.gov/study/NCT07318714",
"title": "A Phase 1/2 Multicenter, Open-label, Dose Escalation Study Followed by a Randomized, Double-blind Sham-controlled Dose Expansion Study to Evaluate the Safety, Tolerability and Efficacy of ASP2246 in Adult Participants Who Have Motor Dysfunction Associated With Late Subacute to Chronic Ischemic Stroke Due to Supratentorial Perforator Area Infarction",
"has_exemption": false,
"start_date": "2026-02-09",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Astellas Pharma Inc",
"sponsor_slug": "astellas-pharma-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06625190",
"publication_url": "https://clinicaltrials.gov/study/NCT06625190",
"title": "Allogeneic Stem Cell Transplantation Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion With Zoledronic Acid in Combination to Treat Pediatric, Adolescent, and Young Adult Patients With Relapsed/Refractory Solid Tumors",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07290621",
"publication_url": "https://clinicaltrials.gov/study/NCT07290621",
"title": "Phase II Trial of Neoadjuvant Toripalimab in Combination With Chemotherapy Followed by Transoral Robotic Surgery or Risk/Response Stratified Chemoradiotherapy for Locoregional HPV16+ Oropharyngeal Cancer: TARGET HPV Cohort 2",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07300956",
"publication_url": "https://clinicaltrials.gov/study/NCT07300956",
"title": "Comparing Medication Treatments for Neurodevelopmental Differences in Young Children on Rates of Beneficial Response",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital Medical Center, Cincinnati",
"sponsor_slug": "childrens-hospital-medical-center-cincinnati",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06824649",
"publication_url": "https://clinicaltrials.gov/study/NCT06824649",
"title": "SMART Use of Biologics in Chronic Rhinosinusitis With Nasal Polyposis",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical University of South Carolina",
"sponsor_slug": "medical-university-of-south-carolina",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07166393",
"publication_url": "https://clinicaltrials.gov/study/NCT07166393",
"title": "Multi-institutional Phase 2/3 Trial of Valproic Acid in Patients With Moderate to Severe Traumatic Brain Injury",
"has_exemption": false,
"start_date": "2026-05-31",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwestern University",
"sponsor_slug": "northwestern-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07129759",
"publication_url": "https://clinicaltrials.gov/study/NCT07129759",
"title": "A Long-term Extension Study to Evaluate the Safety and Tolerability of Daily Oral LUM-201 in Children With Growth Hormone Deficiency (GHD)",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2030-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Lumos Pharma",
"sponsor_slug": "lumos-pharma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06315322",
"publication_url": "https://clinicaltrials.gov/study/NCT06315322",
"title": "A MULTICENTER, OPEN-LABEL, SINGLE-ARM STUDY TO EVALUATE LONG-TERM SAFETY AND TOLERABILITY OF BRIVARACETAM IN STUDY PARTICIPANTS WITH CHILDHOOD ABSENCE EPILEPSY OR JUVENILE ABSENCE EPILEPSY",
"has_exemption": false,
"start_date": "2024-07-10",
"completion_date": "2030-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "UCB Biopharma SRL",
"sponsor_slug": "ucb-biopharma-srl",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06532123",
"publication_url": "https://clinicaltrials.gov/study/NCT06532123",
"title": "Mechanisms of Improving Fecal Continence Muscles Motor Function in Health and Disease",
"has_exemption": false,
"start_date": "2025-07-15",
"completion_date": "2030-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05713799",
"publication_url": "https://clinicaltrials.gov/study/NCT05713799",
"title": "Phase II Trial of the Combination of Alpha-lipoic Acid and Mirabegron in Women and in Men With Obesity",
"has_exemption": false,
"start_date": "2026-02-01",
"completion_date": "2030-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
"sponsor_slug": "national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07206849",
"publication_url": "https://clinicaltrials.gov/study/NCT07206849",
"title": "A Phase 2 Study of Tovorafenib in Pediatric and Young Adult Patients Newly Diagnosed With High-Grade Glioma (HGG), Including Diffuse Intrinsic Pontine Glioma (DIPG), Which Harbor Alterations in the Mitogen-Activated Protein Kinase (MAPK) Pathway",
"has_exemption": false,
"start_date": "2026-03-01",
"completion_date": "2030-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Nationwide Children's Hospital",
"sponsor_slug": "nationwide-childrens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06965114",
"publication_url": "https://clinicaltrials.gov/study/NCT06965114",
"title": "A Phase 1 Study of Combination Tovorafenib (DAY101) and Rituximab Treatment in Relapsed or Refractory Classical Hairy Cell Leukemia and Phase 2 Randomized Study Comparing Tovorafenib (DAY101) and Rituximab With Cladribine and Rituximab for Front-Line Treatment of Classical Hairy Cell Leukemia",
"has_exemption": false,
"start_date": "2026-06-27",
"completion_date": "2030-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04200729",
"publication_url": "https://clinicaltrials.gov/study/NCT04200729",
"title": "Povidone-iodine Irrigation for Prevention of Intra-abdominal Abscess in Pediatric Perforated Appendicitis",
"has_exemption": false,
"start_date": "2027-03-01",
"completion_date": "2030-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center, Houston",
"sponsor_slug": "the-university-of-texas-health-science-center-houston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07226869",
"publication_url": "https://clinicaltrials.gov/study/NCT07226869",
"title": "Computer Guided Microwave Liver Ablation",
"has_exemption": false,
"start_date": "2026-03-02",
"completion_date": "2030-03-02",
"has_results": false,
"results_due": false,
"sponsor_name": "NE Scientific INC",
"sponsor_slug": "ne-scientific-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05952557",
"publication_url": "https://clinicaltrials.gov/study/NCT05952557",
"title": "CAMBRIA-2: A Phase III, Open-Label, Randomised Study to Assess the Efficacy and Safety of Camizestrant (AZD9833, a Next Generation, Oral Selective Estrogen Receptor Degrader) vs Standard Endocrine Therapy (Aromatase Inhibitor or Tamoxifen) as Adjuvant Treatment for Patients With ER+/HER2- Early Breast Cancer and an Intermediate-High or High Risk of Recurrence Who Have Completed Definitive Locoregional Treatment and Have No Evidence of Disease",
"has_exemption": false,
"start_date": "2023-10-05",
"completion_date": "2030-03-04",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06899126",
"publication_url": "https://clinicaltrials.gov/study/NCT06899126",
"title": "A Phase 3, Multicenter, Randomized, Open-label Trial of Trastuzumab Deruxtecan in Combination With Pembrolizumab Versus Platinum-based Chemotherapy in Combination With Pembrolizumab, as First-line Therapy in Participants With Locally Advanced Unresectable or Metastatic HER2 Overexpressing and PD-L1 TPS <50% Non-squamous Non-small Cell Lung Cancer (DESTINY-Lung06)",
"has_exemption": false,
"start_date": "2025-10-24",
"completion_date": "2030-03-05",
"has_results": false,
"results_due": false,
"sponsor_name": "Daiichi Sankyo",
"sponsor_slug": "daiichi-sankyo",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03148418",
"publication_url": "https://clinicaltrials.gov/study/NCT03148418",
"title": "An Open-Label, Multicenter Extension and Long-Term Observational Study in Patients Previously Enrolled in a Genentech- and/or F. Hoffmann-La Roche Ltd-Sponsored Atezolizumab Study",
"has_exemption": false,
"start_date": "2017-09-20",
"completion_date": "2030-03-06",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06869551",
"publication_url": "https://clinicaltrials.gov/study/NCT06869551",
"title": "A Phase 3, Multicenter, Double-blind, Placebo-controlled, Randomized Withdrawal Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of Deucravacitinib in Children and Adolescents From 5 to Less Than 18 Years of Age With Active Juvenile Psoriatic Arthritis",
"has_exemption": false,
"start_date": "2025-03-13",
"completion_date": "2030-03-06",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05837897",
"publication_url": "https://clinicaltrials.gov/study/NCT05837897",
"title": "A Phase 3, Multicenter, Randomized, Parallel-Group, Double-blind, Placebo-Controlled Induction Study Followed by an Open-label Extension Period to Evaluate the Efficacy and Safety of Intravenous Vedolizumab (300 mg) Infusion Treatment in Subjects in China With Moderately to Severely Active Crohn's Disease",
"has_exemption": false,
"start_date": "2023-06-16",
"completion_date": "2030-03-08",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05432791",
"publication_url": "https://clinicaltrials.gov/study/NCT05432791",
"title": "A Randomized Phase 2/3 Study of Olaparib Plus Temozolomide Versus Investigator's Choice for the Treatment of Patients With Advanced Uterine Leiomyosarcoma After Progression on Prior Chemotherapy",
"has_exemption": false,
"start_date": "2023-03-30",
"completion_date": "2030-03-09",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05785767",
"publication_url": "https://clinicaltrials.gov/study/NCT05785767",
"title": "A Randomized, Double-Blind Phase 2/3 Study of Fianlimab (Anti-LAG-3 Antibody) in Combination With Cemiplimab (Anti-PD-1 Antibody) Versus Cemiplimab Monotherapy in First-Line Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) With Tumors Expressing PD-L1 ≥50%",
"has_exemption": false,
"start_date": "2023-06-30",
"completion_date": "2030-03-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07172022",
"publication_url": "https://clinicaltrials.gov/study/NCT07172022",
"title": "A Phase II, Randomized, Double-blind, Placebo-controlled, Multicenter Study Evaluating Efficacy, Safety, and Pharmacokinetics of Crovalimab in Patients With Antiphospholipid Syndrome (APS)",
"has_exemption": false,
"start_date": "2026-03-16",
"completion_date": "2030-03-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05646381",
"publication_url": "https://clinicaltrials.gov/study/NCT05646381",
"title": "A Randomized Double-blind, Placebo-controlled, Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis [Lp(a)FRONTIERS CAVS]",
"has_exemption": false,
"start_date": "2024-03-07",
"completion_date": "2030-03-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06987539",
"publication_url": "https://clinicaltrials.gov/study/NCT06987539",
"title": "A Phase 2 Open-label Multicenter Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children From 2 Years to Less Than 18 Years of Age With Generalized Myasthenia Gravis (gMG)",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2030-03-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05691478",
"publication_url": "https://clinicaltrials.gov/study/NCT05691478",
"title": "A Feasibility and Randomized Phase 2/3 Study of the VEGFR2/MET Inhibitor Cabozantinib in Combination With Cytotoxic Chemotherapy for Newly Diagnosed Osteosarcoma",
"has_exemption": false,
"start_date": "2023-03-03",
"completion_date": "2030-03-20",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06042569",
"publication_url": "https://clinicaltrials.gov/study/NCT06042569",
"title": "Dose Reduction of Docetaxel-Based Chemotherapy in Vulnerable Older Women With Early-Stage Breast Cancer (DOROTHY)",
"has_exemption": false,
"start_date": "2024-09-16",
"completion_date": "2030-03-20",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07253285",
"publication_url": "https://clinicaltrials.gov/study/NCT07253285",
"title": "Efficacy, Safety and Pharmacokinetics of Cagrilintide s.c. 2.4 mg as Monotherapy and in Combination With Semaglutide s.c. 2.4 mg (CagriSema) Once Weekly for Weight Management in Chidren and Adolescents With Overweight or Obesity",
"has_exemption": false,
"start_date": "2026-01-08",
"completion_date": "2030-03-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Novo Nordisk A/S",
"sponsor_slug": "novo-nordisk-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07178301",
"publication_url": "https://clinicaltrials.gov/study/NCT07178301",
"title": "Elective Neck Dosing in Low Risk Oropharyngeal Human Papillomavirus-Related Cancer Treatment (ENLIGHT): A Single Arm Prospective Phase II Assessing 30 Gy Elective Neck Dose",
"has_exemption": false,
"start_date": "2026-03-20",
"completion_date": "2030-03-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwestern University",
"sponsor_slug": "northwestern-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06347055",
"publication_url": "https://clinicaltrials.gov/study/NCT06347055",
"title": "Neuronavigated Non-invasive Brain Stimulation for Nicotine Dependence.",
"has_exemption": false,
"start_date": "2024-10-01",
"completion_date": "2030-03-25",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Missouri-Columbia",
"sponsor_slug": "university-of-missouri-columbia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05352919",
"publication_url": "https://clinicaltrials.gov/study/NCT05352919",
"title": "A Multicenter, Randomized, Dose-Blind, Phase 3 Long-Term Extension Study to Evaluate Continuous Safety and Efficacy of Litifilimab (BIIB059) in Adult Participants With Active Systemic Lupus Erythematosus",
"has_exemption": false,
"start_date": "2022-06-10",
"completion_date": "2030-03-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Biogen",
"sponsor_slug": "biogen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07222800",
"publication_url": "https://clinicaltrials.gov/study/NCT07222800",
"title": "AN INTERVENTIONAL, PHASE 3, DOUBLE-BLIND, RANDOMIZED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PF-08634404 IN COMBINATION WITH CHEMOTHERAPY VERSUS BEVACIZUMAB IN COMBINATION WITH CHEMOTHERAPY IN TREATMENT-NAÏVE PARTICIPANTS WITH METASTATIC COLORECTAL CANCER",
"has_exemption": false,
"start_date": "2025-12-11",
"completion_date": "2030-03-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06439693",
"publication_url": "https://clinicaltrials.gov/study/NCT06439693",
"title": "A Single-Arm, Phase II Study of Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast Cancer: The SAPPHO Study",
"has_exemption": false,
"start_date": "2024-08-08",
"completion_date": "2030-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Dana-Farber Cancer Institute",
"sponsor_slug": "dana-farber-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02050113",
"publication_url": "https://clinicaltrials.gov/study/NCT02050113",
"title": "Complex Aortic Aneurysm Repair Using Physician Modified Endografts and Custom Made Devices",
"has_exemption": false,
"start_date": "2014-03-31",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Andres Schanzer",
"sponsor_slug": "andres-schanzer",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03048201",
"publication_url": "https://clinicaltrials.gov/study/NCT03048201",
"title": "Post-market Registry Study on the Physica System Total Knee Replacement",
"has_exemption": false,
"start_date": "2017-03-24",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Limacorporate S.p.a",
"sponsor_slug": "limacorporate-spa",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03674372",
"publication_url": "https://clinicaltrials.gov/study/NCT03674372",
"title": "Pilot Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) in Severe Right and Left Congenital Diaphragmatic Hernia (CDH)",
"has_exemption": false,
"start_date": "2018-11-16",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03959085",
"publication_url": "https://clinicaltrials.gov/study/NCT03959085",
"title": "A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (NSC#: 772518) for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLy",
"has_exemption": false,
"start_date": "2019-10-31",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Oncology Group",
"sponsor_slug": "childrens-oncology-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04683250",
"publication_url": "https://clinicaltrials.gov/study/NCT04683250",
"title": "Phase I/II Study of the Selective RET Inhibitor TAS0953/HM06 in Patients with Advanced Solid Tumors with RET Gene Abnormalities",
"has_exemption": false,
"start_date": "2020-12-16",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Taiho Pharmaceutical Co., Ltd.",
"sponsor_slug": "taiho-pharmaceutical-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05286801",
"publication_url": "https://clinicaltrials.gov/study/NCT05286801",
"title": "A Phase 1/2 Study of Tiragolumab (NSC# 827799) and Atezolizumab (NSC# 783608) in Patients With Relapsed or Refractory SMARCB1 or SMARCA4 Deficient Tumors",
"has_exemption": false,
"start_date": "2022-11-17",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05259527",
"publication_url": "https://clinicaltrials.gov/study/NCT05259527",
"title": "Impact of Vitamin D Supplementation on Reported Rates of Taxane-Induced Neuropathy",
"has_exemption": false,
"start_date": "2022-12-19",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Virginia Commonwealth University",
"sponsor_slug": "virginia-commonwealth-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06153173",
"publication_url": "https://clinicaltrials.gov/study/NCT06153173",
"title": "A Phase II Trial of the MEK Inhibitor Mirdametinib in Histiocytic Disorders",
"has_exemption": false,
"start_date": "2024-02-05",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital Medical Center, Cincinnati",
"sponsor_slug": "childrens-hospital-medical-center-cincinnati",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06013865",
"publication_url": "https://clinicaltrials.gov/study/NCT06013865",
"title": "An Exploratory Investigation of the Safety of Empagliflozin in Kidney Transplant Recipients (SEKTR)",
"has_exemption": false,
"start_date": "2024-04-05",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06424756",
"publication_url": "https://clinicaltrials.gov/study/NCT06424756",
"title": "Role of Mitochondria-derived Oxidative Stress on Microvascular Endothelial Function in Healthy Non-Hispanic Black and White Adults",
"has_exemption": false,
"start_date": "2024-07-01",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Georgia",
"sponsor_slug": "university-of-georgia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06802315",
"publication_url": "https://clinicaltrials.gov/study/NCT06802315",
"title": "A Phase II Study of Intensity Modulated Total Marrow Irradiation (IM-TMI) in Addition to Myeloablative Fludarabine/Busulfan and Post-Transplant Cyclophosphamide (PTCY) for Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk AML, CML, and MDS",
"has_exemption": false,
"start_date": "2025-02-04",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Illinois at Chicago",
"sponsor_slug": "university-of-illinois-at-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06926790",
"publication_url": "https://clinicaltrials.gov/study/NCT06926790",
"title": "Neoadjuvant Nivolumab Plus Ipilimumab in Resectable Non-small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2025-02-17",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "The First Affiliated Hospital of Guangzhou Medical University",
"sponsor_slug": "the-first-affiliated-hospital-of-guangzhou-medical-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06805305",
"publication_url": "https://clinicaltrials.gov/study/NCT06805305",
"title": "Randomized Study of DOC1021 Dendritic Cell Immunotherapy in Combination With Standard of Care for Newly Diagnosed Adult Glioblastoma",
"has_exemption": false,
"start_date": "2025-03-17",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Diakonos Oncology Corporation",
"sponsor_slug": "diakonos-oncology-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06847269",
"publication_url": "https://clinicaltrials.gov/study/NCT06847269",
"title": "CAR T CELL Therapy for Pediatric, Adolescent and Young Adult Patients With CD19-Positive Leukemia: An Investigation of Lymphodepleting Chemotherapy Pharmacokinetics",
"has_exemption": false,
"start_date": "2025-05-21",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Jude Children's Research Hospital",
"sponsor_slug": "st-jude-childrens-research-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07193511",
"publication_url": "https://clinicaltrials.gov/study/NCT07193511",
"title": "A Phase 1/2, First-in-Human Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of AVZO-103, a Nectin4/Trop2 ADC, as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors",
"has_exemption": false,
"start_date": "2025-10-02",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Avenzo Therapeutics, Inc.",
"sponsor_slug": "avenzo-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06937866",
"publication_url": "https://clinicaltrials.gov/study/NCT06937866",
"title": "Maintenance Zanzalintinib With Oral Etoposide Following High-dose Chemotherapy in Patients With Relapsed Metastatic Germ-cell Tumor",
"has_exemption": false,
"start_date": "2025-11-12",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Indiana University",
"sponsor_slug": "indiana-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07108270",
"publication_url": "https://clinicaltrials.gov/study/NCT07108270",
"title": "A Phase 2, Multicenter, Open-label, Single Arm Study of Dostarlimab Plus Carboplatin-paclitaxel Followed by Dostarlimab Monotherapy in Participants With dMMR/MSI-H Primary Advanced or Recurrent Endometrial Cancer in China (China RUBY)",
"has_exemption": false,
"start_date": "2025-11-27",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07159841",
"publication_url": "https://clinicaltrials.gov/study/NCT07159841",
"title": "A Phase 2/3 Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Atumelnant Treatment in Pediatric Participants With Congenital Adrenal Hyperplasia Including a Long-Term Extension",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Crinetics Pharmaceuticals Inc.",
"sponsor_slug": "crinetics-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07284758",
"publication_url": "https://clinicaltrials.gov/study/NCT07284758",
"title": "A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Subjects With Relapsed/Refractory Multiple Myeloma",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "C4 Therapeutics, Inc.",
"sponsor_slug": "c4-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07286006",
"publication_url": "https://clinicaltrials.gov/study/NCT07286006",
"title": "A Long-Term Extension Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Patients With Graves' Disease",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Immunovant Sciences GmbH",
"sponsor_slug": "immunovant-sciences-gmbh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07281027",
"publication_url": "https://clinicaltrials.gov/study/NCT07281027",
"title": "Comparing the Effects of Anakinra and Tocilizumab on Outcomes in Patients With New-Onset Refractory Status Epilepticus",
"has_exemption": false,
"start_date": "2026-03-01",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07158242",
"publication_url": "https://clinicaltrials.gov/study/NCT07158242",
"title": "A Phase III Randomized Double-Blind Multi-Center Treat-Through Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Children Aged 2 - 17 Years With Moderately to Severely Active Ulcerative Colitis",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07262060",
"publication_url": "https://clinicaltrials.gov/study/NCT07262060",
"title": "Optimizing Caffeine Therapy for Hypoxia in Preterm Neonates: A Randomized Trial Assessing Efficacy, Acute Kidney and Brain Injury, Safety, and Pharmacokinetics",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Wisconsin, Madison",
"sponsor_slug": "university-of-wisconsin-madison",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07281768",
"publication_url": "https://clinicaltrials.gov/study/NCT07281768",
"title": "Combining Capecitabine/Oxaliplatin Chemotherapy With Cemiplimab Alone or in Combination With Fianlimab or REGN7075 for the Neoadjuvant Treatment of Locally Advanced Rectal Cancer",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins",
"sponsor_slug": "sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07346144",
"publication_url": "https://clinicaltrials.gov/study/NCT07346144",
"title": "A Phase I/II Study of an AAV-1 Mediated Dual-Payload Gene Therapy in Patients With High Grade Glioma",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Trogenix ltd",
"sponsor_slug": "trogenix-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07187466",
"publication_url": "https://clinicaltrials.gov/study/NCT07187466",
"title": "Sequential Multiple Assignment Randomized Trial to Treat Urinary Symptoms in Parkinson Disease",
"has_exemption": false,
"start_date": "2026-04-01",
"completion_date": "2030-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04042402",
"publication_url": "https://clinicaltrials.gov/study/NCT04042402",
"title": "An Open-Label Roll-Over Study to Evaluate the Long-Term Safety and Efficacy of DCR-PHXC Solution for Injection (Subcutaneous Use) in Patients With Primary Hyperoxaluria",
"has_exemption": false,
"start_date": "2019-07-09",
"completion_date": "2030-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Dicerna Pharmaceuticals, Inc., a Novo Nordisk company",
"sponsor_slug": "dicerna-pharmaceuticals-inc-a-novo-nordisk-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07112287",
"publication_url": "https://clinicaltrials.gov/study/NCT07112287",
"title": "MyeloGen: Germline Testing for Predisposition to Myeloid Malignancies",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2030-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Christopher Reilly",
"sponsor_slug": "christopher-reilly",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07029776",
"publication_url": "https://clinicaltrials.gov/study/NCT07029776",
"title": "A Phase 2 Study Exploring the Use of Bispecific Antibodies to Improve Progression Free Survival in Patients With High-Risk Newly Diagnosed Multiple Myeloma (MMulti-Immune HR)",
"has_exemption": false,
"start_date": "2026-04-01",
"completion_date": "2030-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Arkansas",
"sponsor_slug": "university-of-arkansas",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05972629",
"publication_url": "https://clinicaltrials.gov/study/NCT05972629",
"title": "A Phase 1/Phase 2, Open-label, Dose-escalation, and Dose Expansion Study to Evaluate the Safety, Tolerability, and Efficacy of SAR444836, an Adeno-associated Viral Vector-mediated Gene Transfer of Human Phenylalanine Hydroxylase, in Adult Participants With Phenylketonuria",
"has_exemption": false,
"start_date": "2023-08-07",
"completion_date": "2030-04-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07326709",
"publication_url": "https://clinicaltrials.gov/study/NCT07326709",
"title": "A Randomized, Placebo-controlled, Double-blind Phase 3 Study to Evaluate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease",
"has_exemption": false,
"start_date": "2026-06-01",
"completion_date": "2030-04-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07146906",
"publication_url": "https://clinicaltrials.gov/study/NCT07146906",
"title": "An Open-label, Multicenter Study to Assess the Effect of Zigakibart Treatment on Histologic, Circulating, and Excreted Markers of Kidney Disease and Dysfunction in Adult Patients With IgA Nephropathy.",
"has_exemption": false,
"start_date": "2025-11-18",
"completion_date": "2030-04-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03718403",
"publication_url": "https://clinicaltrials.gov/study/NCT03718403",
"title": "Effect of Theophylline in Pseudohypoparathyroidism",
"has_exemption": false,
"start_date": "2019-11-11",
"completion_date": "2030-04-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05582993",
"publication_url": "https://clinicaltrials.gov/study/NCT05582993",
"title": "A Phase 3, Prospective, Open-label, Uncontrolled, Multicenter Study on Efficacy and Safety of Prophylaxis With Vonicog Alfa (rVWF) in Children Diagnosed With Severe Von Willebrand Disease",
"has_exemption": false,
"start_date": "2024-11-06",
"completion_date": "2030-04-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06632977",
"publication_url": "https://clinicaltrials.gov/study/NCT06632977",
"title": "PREcision DIagnostics in Prostate Cancer Treatment (PREDICT)",
"has_exemption": false,
"start_date": "2025-02-06",
"completion_date": "2030-04-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Alliance for Clinical Trials in Oncology",
"sponsor_slug": "alliance-for-clinical-trials-in-oncology",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07061574",
"publication_url": "https://clinicaltrials.gov/study/NCT07061574",
"title": "A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes",
"has_exemption": false,
"start_date": "2025-12-30",
"completion_date": "2030-04-15",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06397703",
"publication_url": "https://clinicaltrials.gov/study/NCT06397703",
"title": "A Phase II Prospective 2-Arm Cohort Interventional Trial Utilizing Ultra-Hypofractionated SBRT With or Without Short Course Androgen Deprivation Therapy For Unfavorable Intermediate Risk Prostate Cancer",
"has_exemption": false,
"start_date": "2024-04-16",
"completion_date": "2030-04-16",
"has_results": false,
"results_due": false,
"sponsor_name": "NYU Langone Health",
"sponsor_slug": "nyu-langone-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06686394",
"publication_url": "https://clinicaltrials.gov/study/NCT06686394",
"title": "HERTHENA-Breast-01: A Phase 1b/2, Multicenter, Open-label, Dose-Finding Study to Evaluate the Safety and Antitumor Activity of Patritumab Deruxtecan in Participants With HER2 Positive Unresectable Locally Advanced Breast Cancer or Metastatic Breast Cancer",
"has_exemption": false,
"start_date": "2025-02-26",
"completion_date": "2030-04-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06133972",
"publication_url": "https://clinicaltrials.gov/study/NCT06133972",
"title": "A Randomized, Double-blind, Placebo-controlled Extension Study to Assess the Long-term Safety and Tolerability of Ianalumab in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE Extension)",
"has_exemption": false,
"start_date": "2024-05-21",
"completion_date": "2030-04-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07153497",
"publication_url": "https://clinicaltrials.gov/study/NCT07153497",
"title": "A Randomized Phase 2 Trial of Olutasidenib-Based Therapies in Patients With Newly Diagnosed IDH1-Mutant Myeloid Malignancies: A MyeloMATCH Substudy",
"has_exemption": false,
"start_date": "2026-05-27",
"completion_date": "2030-04-26",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04806854",
"publication_url": "https://clinicaltrials.gov/study/NCT04806854",
"title": "A Single-Center, Randomized, Open-Label, Parallel Arm Study of Daily Oral LUM-201 in Naive-to-Treatment, Prepubertal Children With Idiopathic Pediatric Growth Hormone Deficiency (PGHD)",
"has_exemption": false,
"start_date": "2021-07-14",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Lumos Pharma",
"sponsor_slug": "lumos-pharma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05919108",
"publication_url": "https://clinicaltrials.gov/study/NCT05919108",
"title": "Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers",
"has_exemption": false,
"start_date": "2024-05-30",
"completion_date": "2030-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Vanderbilt-Ingram Cancer Center",
"sponsor_slug": "vanderbilt-ingram-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
}
]
}